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Abstract
The activation of B cells culminates in a fate decision between plasma cell or memory B
cell differentiation pathways. Mice lacking the Ets transcription factor Spi-B exhibit
impaired secondary antibody (Ab)-forming responses. The role of the related factor Spi-C
in Ab-forming responses remains unknown. Using Spib-/-Spic+/- mice, we showed that
heterozygosity of Spi-C rescued reductions in secondary IgG1-secreting cell frequencies.
Spib-/- and Spib-/-Spic+/- B cells generated increased frequencies of CD138+ cells, relative
to WT B cells. Spib-/- B cells underwent accelerated differentiation compared to WT B
cells, while Spib-/-Spic+/- B cells exhibited a lag in differentiation. Gene expression analysis
indicated that Bach2 was downregulated in CD138+ Spib-/- cells. ChIP experiments
suggested that Spi-B and Spi-C were enriched at Ets binding sites located within Bach2 in
stimulated B cells. Our results point to a novel role for Spi-C in opposing the function of
Spi-B in activated B cells.
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Chapter 1: Introduction

1.1 The B cell: A Look Inside the Immune Arsenal
The immune system contributes to the establishment and dynamic maintenance of
homeostasis throughout an organism’s life. Its physiological mandate is to protect the
organism from infectious pathogens, to eliminate malignancies, to tolerate commensal
bacteria, to recognize host tissues and to assist in their repair (Parham, 2015). In higher
vertebrates, this complex balancing act is carried out via two complementary arms—known
as innate and adaptive immunity. The innate arm constitutes a first line of defense against
invading microorganisms, and is primarily required for early recognition and short-term
control of infection. Innate immunity provides non-pathogen-specific protection in
prokaryotic and eukaryotic species, likely borne out of a primal need for early unicellular
organisms to accurately discriminate between ‘self’ and ‘non-self’ entities (Janeway,
1992).
Despite its complexity and well-honed coordination, the innate arm is intrinsically limited
in its ability to resolve infections, due to its lack of specificity and inability to form
‘memories’ of past pathogenic encounters. The second barrier to infectious or malignant
non-self, the adaptive arm, is recruited by innate-derived inflammation. Adaptive
immunity, unlike its innate counterpart, specializes in the generation of pathogen-specific
responses, which are improved upon iterative exposures. The ability of adaptive responses
to improve upon repeated encounters, in terms of both quality and rapidity, has been termed
memory (Parham, 2015).
The functions of the adaptive arm are primarily carried out by B and T lymphocytes. B
cells collectively constitute a diverse population of immune cells, and are unique in their
ability to give rise to antibody-forming cells. Antibodies are secreted effector proteins
which display binding specificities to a near infinite array of pathogen-associated
molecular conformations. Upon binding their target epitope, antibodies mediate the
resolution of infections via neutralization, opsonization and complement activation, or by
inducing antibody-dependent cell-mediated cytotoxicity (Diebolder et al., 2014; Tang et
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al., 2007; Vidarsson, Dekkers, & Rispens, 2014). In addition to their ability to generate
plasma cells, B cells can give rise to memory B cells—a population of long-lived, antigenspecific cells poised to induce timely antibody-forming responses in the event of pathogen
re-encounter (Kurosaki, Kometani, & Ise, 2015). Modern vaccines have long capitalized
upon the ability of B cells to generate long-lasting protection against a wide range of
infectious agents (Buisman, de Rond, Öztürk, ten Hulscher, & van Binnendijk, 2009).
Current challenges to vaccine development, such as the generation of robust and lasting
responses in elderly patients, highlight a pressing need to better understand B cell biology,
and the interplay of factors which shape antibody-forming responses to immunization or
natural infection.

1.2 Murine B cell development
B cell development is ongoing throughout life, and proceeds, in its earliest stages, from the
commitment of pluripotent hematopoietic stem cells to the lymphoid fate within the bone
marrow (BM) (Hardy, Kincade, & Dorshkind, 2007). Self-renewing, pluripotent CD34+
hematopoietic stem cells give rise to the three lineages that make up blood cells and
platelets—namely the myeloid, erythroid and lymphoid lineages (Parham, 2015).
Following its commitment to the lymphoid fate, and prior to its egress from the BM, a
murine B cell precursor sequentially enters through five stages of development: the prepro-B cell, pro-B cell, large and small pre-B cell, and finally immature B cell stages (Hardy
et al., 2007). In 1991, an effort led by Hardy and colleagues resulted in the codification of
murine B cell development (Hardy et al., 2007; Hardy, Carmack, Shinton, Kemp, &
Hayakawa, 1991). The ensuing model relies on phenotypic and functional markers, along
with immunoglobin heavy chain (IgH) and light chain (IgL) rearrangement status to
identify developmental milestones in B cells (Hardy et al., 1991). Progression from one
stage to the next is dependent upon successful rearrangements of immunoglobulin gene
regions, which ultimately give rise to a collectively diverse B cell receptor (BCR)
repertoire (Hardy et al., 2007, 1991). As progenitor B cells progress through these
developmental stages, sequential rearrangement of Ig gene regions is initiated by the
recombination-activating genes (RAG1/2) proteins, which are guided by recombination
signal sequences (RSS) to generate double-stranded DNA breaks (Oettinger, Schatz,
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Gorka, & Baltimore, 1990). Repair of RAG-generated DNA breaks relies on the process
of non-homologous end-joining, allowing for the generation of a staggeringly diverse
repertoire of BCR specificities (Herzog, Reth, & Jumaa, 2009; Yaari et al., 2015).
Recombination of a limited number of Ig genes thus confers onto pools of
immunocompetent B cells the ability to recognize an estimated 1014 antigens (Herzog et
al., 2009; Yaari et al., 2015).

1.2.1

Intramedullary development

In the bone marrow, B220-expressing pre-pro-B cells and pro-B cells undergo
rearrangement of heavy chain DH-JH regions, and VH-DHJH regions, respectively (Hardy et
al., 1991). B220+CD43+CD24-AA4.1+ pre-pro-B cells (Hardy Fraction A) are somewhat
unique amongst B cell progenitors in their ability to give rise to other lymphoid cell types,
including NK cells, as they express low levels of the transcription factor Pax-5 (Rolink et
al., 1996; Rolink, Nutt, Melchers, & Busslinger, 1999). Pax-5 promotes lineage
commitment in B cells by rendering Ig loci accessible for VDJ recombination, as well as
by inducing the expression of lineage-specific markers, such as CD19 (Busslinger, Nutt,
Heavey, & Rolink, 1999; Kaneko et al., 1998). Progression from the earliest stages of B
cell development relies on extrinsic cues provided by BM stromal cells. Perhaps most
notably, interleukin (IL)-7 drives the survival and proliferation of pro-B cells in a STAT5mediated manner, and is critically involved in promoting the accessibility of VH and DH
genes (Corcoran, Riddell, Krooshoop, & Venkitaraman, 1998; Malin et al., 2010).
Following successful rearrangement of the Igµ locus, B220+CD43+CD24+ pro-B cells
(Hardy Fraction B/C) transition to the large pre-B cell stage (Fraction C’), wherein these
cells begin expressing assembled pre-BCRs on their surface (Hardy et al., 2007).
Expression of the pre-BCR, consisting of the rearranged µ chain along with CD79a, CD79b
and surrogate light chain (SLC) proteins, represents an important checkpoint in B cell
development (Kitamura, Roes, Kühn, & Rajewsky, 1991). Concurrent signaling through
the pre-BCR and IL-7R transiently drives proliferation throughout the large pre-B cell
stage (Clark, Mandal, Ochiai, & Singh, 2014). This proliferative burst seems to be
inherently self-limited, as the pre-BCR antagonizes IL-7 signaling, as well as its own
constituents and downstream effectors (namely, SLC proteins, BLNK and SYK), as is
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reviewed elsewhere (Clark et al., 2014). The differentiation pressure provided by the preBCR subsequently allows the developing B cell to enter the resting state required to initiate
IgL rearrangement (Rajewsky, 1996). The B220+CD43-CD24+ small pre-B cell (Fraction
D) undergoes its transition to the immature B cell stage (Fraction E) after producing a
successful in-frame rearrangement of its κ or λ IgL loci, resulting in its expression of
surface IgM (Kitamura et al., 1991).

1.2.2

Extramedullary development

The developing B cell pool carries an important autoreactive potential (Janeway, Travers,
& Walport, 2001). A 2003 report estimated that 55-75% of early immature B cells
displayed detectable self-reactivity, through an analysis of the Igµ complementaritydetermining region (CDR)-3 (Wardemann et al., 2003). In the BM, BCR-mediated
recognition of multivalent self-Ags induces RAG1/2 re-expression in IgM+ B cells, in an
attempt to generate non-self-reactive BCRs—a process known as receptor editing. Failure
to abolish self-reactivity of the BCR results in apoptosis (Tiegs, Russell, & Nemazee,
1993). Following their negative selection in the BM, immature B cells enter the transitional
stages—termed T1 and T2 (Allman et al., 2001). Guided by chemotactic signals, such as
increased levels of sphingosin-1-phosphate (SIP) in vasculature, T1 B cells enter into
circulation via BM sinusoids (Chung, Silverman, & Monroe, 2003; Pappu et al., 2007). En
route to the secondary lymphoid organs (SLOs), B220+AA4.1+ T1 B cells are once again
subjected to negative selection—as binding of the BCR to soluble Ags in the blood results
in B cell anergy (Allman et al., 2001; Goodnow et al., 1988). Upon entry into the
periarteriolar lymphoid sheet, T1 cells mature into CD23+CD21+ T2 B cells, which are
found within the follicle (Chung et al., 2003; Loder et al., 1999). The T2-mature B cell
transition appears to be reliant upon the positive selection of T2 cells via the B cell
activating factor (BAFF) and strong BCR signaling (Chung et al., 2003; Pillai & Cariappa,
2009; Schiemann et al., 2001). Long-lived mature B cells may then re-enter into
circulation, relying on CCL21 and CCL19 gradients to guide their diapedesis back into
SLOs [Reviewed in (Stein & Nombela-Arrieta, 2005)].

1.3 Mature B cell subsets
Mature B cells display an astounding degree of phenotypic and functional heterogeneity—
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and have, on the basis of their differences, been categorized into various populations and
subsets. Major subsets have been outlined in this section.

1.3.1

B-1 cells

B-1 cells constitute a unique population of B lymphocytes which localize primarily within
pleural and peritoneal cavities, and exhibit the cell surface phenotype IgMhiIgDloCD23CD21lo (Kantor & Herzenberg, 1993). The identification of this distinct subset was
prompted by reports describing the presence of ‘natural’ antibodies (nAbs)—antibodies
which displayed broad self-reactivity and occurred in the absence of exogenous antigen
exposure (Holodick, Rodríguez-Zhurbenko, & Hernández, 2017). Some level of
heterogeneity exists within the B-1 subset, which has been further subdivided into B-1a
(CD5-expressing) and B-1b (CD5-lacking) fractions (Berland & Wortis, 2002). While
peritoneum-derived B-1 cells can express CD11b, spleen-resident B-1 cells extinguish
expression of this marker (Ghosn, Yang, Tung, Herzenberg, & Herzenberg, 2008). B-1
cells have, since their discovery by Hayakawa and colleagues, been implicated in several
key immune processes—such as protection against microbial infection, B cell development
and apoptotic cell clearance (Baumgarth, 2010; Holodick et al., 2017).
The biology of B-1 cells diverges from that of conventional B lymphocytes in many
important aspects. With regards to development of the B-1 population, the weight of
available evidence points to a switch in the origin of these cells from de novo hematopoietic
development in the fetal liver to self-renewal in the adult peritoneal and pleural cavities [as
Reviewed in (Baumgarth, 2010)]. In terms of activation and function, B-1 cells are
considered T-cell independent (TI), as they are capable of mounting a predominately IgMdriven response to mitogenic stimuli or repetitive polysaccharide epitopes, in the absence
of T cell help (Mond, Lees, & Snapper, 1995; Morris & Rothstein, 1993). B-1-derived
antibodies display reduced junctional diversity, resulting in a more restricted BCR
repertoire relative to that of conventional B-2 cells (Feeney, 1990; Mercolino, Arnold,
Hawkins, & Haughton, 1988). While many have deemed B-1 cells to possess innate-like
character, reports have demonstrated the ability of B-1b cells to generate long-lasting
protection against bacterial pathogens—a hallmark of the adaptive immunity (Alugupalli
et al., 2004; Haas, Poe, Steeber, & Tedder, 2005).
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1.3.2
1.3.2.1

B-2 cells
FO B cells

While the B-2 B cell compartment is formally comprised of both follicular (FO) and
marginal zone (MZ) B cells, the term B-2 has been used more narrowly to differentiate
between ‘conventional’ FO B cells, and the B-1 fraction. FO B cells, which co-express IgD
and IgM, can further be identified on the basis of CD23 and CD21 expression
(CD23+CD21+) (Baumgarth, 2004). Following their maturation from precursor transitional
subsets, as outlined in Section 1.2.2., FO B cells spend most of their lifespan recirculating
and transiting between secondary lymphoid organs (SLOs)—a dynamic process which
promotes potential antigenic encounters at various body sites. Homing of naïve B cells to
SLOs involves their initial attachment to high endothelial venules, within which
endothelial cells express CCL21 and CCL19 (Stein & Nombela-Arrieta, 2005). Following
transmigration, CXCR5-expressing FO B cells relocate to the lymphoid follicle by sensing
follicular dendritic cell-produced CXCL13 (Förster et al., 1996; Stein & Nombela-Arrieta,
2005). Their location within B cell follicles places naïve B cells in ideal proximity to the T
cell zone for future cognate pair interactions (Pillai & Cariappa, 2009). Humoral responses
driven by FO B cells are ultimately T cell-dependent—as the process of FO B cell
activation requires T cell-derived signals (Section 1.4.1) (Parham, 2015). Processes
relating to FO B cell antigen processing, BCR signaling, germinal center entry and terminal
differentiation are outlined in Section 1.4. The current understanding regarding FO B cell
responses is summarized in Figure 1-1.

1.3.2.2

MZ B cells

The marginal zone (MZ) of the spleen, located at the anatomic boundary of red and white
pulp, is home to a distinct subtype of mature B lymphocytes (Kraal, 1992). These MZ B
cells differ from their conventional B cell counterparts in a number of ways—having
previously been denoted as an ‘innate-like’ subset of B lymphocytes (Cerutti, Cols, &
Puga, 2013). While FO B cells bear unique BCRs of narrow specificity on their surface,
MZ B cells possess polyreactive receptors which recognize both self and microbial
epitopes (Cerutti et al., 2013).
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Figure 1-1. Overview of current paradigm for T cell-dependent follicular B cell fate
decisions. Following interactions with primed T cells, activated FO B cells can
differentiate into short-lived antibody-secreting cells (ASCs), GC-independent memory B
cells, or go on to form GCs. While in the GC, B cells undergo class-switch recombination
and affinity maturation. Ultimately, GC B cells may terminally differentiate into plasma
cells, or differentiate into memory B cells.
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In addition to their semi-invariant BCRs, mature MZ B cells express high levels of tolllike receptors (TLRs), and exhibit an IgMhiCD38hiCD21hiCD23- cell surface phenotype
(Oliver, Martin, & Kearney, 1997; Treml et al., 2007).
The positioning of these non-circulating B lymphocytes within highly perfused regions of
the spleen has long been thought critical to their function as antibody-forming sentinels,
which constantly screen for blood-borne pathogens (Martin & Kearney, 2002). The
activation profile of MZ B cells differs from that of FO B cells in a few key aspects. Unlike
FO B cells, MZ B cells can recognize and are primarily activated by T cell-independent
antigens (Balazs, Martin, Zhou, & Kearney, 2002). When stimulated with TLR-4 ligand
lipopolysaccharide (LPS), MZ B cells were shown to proliferate to a greater degree than
FO B cells, but fared relatively poorly when cultured with anti-IgM antibodies (Oliver,
Martin, Gartland, Carter, & Kearney, 1997). Exposure to LPS primarily induced secretion
of IgM and IgG3 antibodies (Oliver, Martin, Gartland, et al., 1997). MZ B cells display
robust antigen-presentation activity to T cells in vitro—meaning that these cells may be
involved in both T cell-dependent and -independent responses (Martin & Kearney, 2002).
Activation of MZ B cells prompts their re-positioning towards the white pulp of the spleen,
where they rapidly differentiate into PCs (Bendelac, Bonneville, & Kearney, 2001). The
rapidity of the MZ B cell antibody response lends support to innate defenses during the
time delay occurring between the onset of primary infections, and the production of high
affinity antibodies by FO B cells (Cerutti et al., 2013).

1.4 Humoral immune responses
1.4.1

T cell-dependent B cell activation

Within lymphoid follicles, naïve B cells are continually exposed to free antigens from
lymphatic fluid or blood, as well as to lymph-borne microorganisms captured by
subcapsular sinus macrophages or follicular dendritic cells (FDCs) (Carrasco & Batista,
2007; Junt et al., 2007; Phan, Grigorova, Okada, & Cyster, 2007). Monomeric or
multimeric antigens induce cross-linking (or clustering) of BCRs on the cell surface,
triggering the activation of downstream signaling networks. BCR engagement results in a
phosphorylation cascade which, in its initiating stages, involves the heterodimeric Igα and
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Igβ subunits, the Src family kinase Lyn and the spleen tyrosine kinase (Syk) (Cheng et al.,
1995; Flaswinkel & Reth, 1994). Scaffold proteins such as B cell linker protein (Blnk)
coordinate the involvement of other downstream cellular networks, such as
phosphoinositide-3-kinase (PI3K) and mitogen-activated protein kinases (MAPK)
pathways (Richards, Davé, Chou, Mamchak, & DeFranco, 2001). Recruitment of Bruton’s
tyrosine kinase (Btk) by PI3K activation further leads to an influx of Ca2+—the magnitude
and duration of which ultimately instructs the activation of the NFκB and NF-AT pathways
(Dal Porto et al., 2004). Signaling through the BCR results in gene expression changes
which promote the transition from the naïve phenotype to that of antigen-experienced B
cells. Notably, B cells upregulate CD69, an early marker of activation, and downregulate
sphingosine-1-phosphate (SIP) receptor 1, which enables their sensing of chemotactic SIP
gradients, thus preventing their egress into circulation (Lo, Xu, Proia, & Cyster, 2005;
Richards et al., 2001).
In addition to inducing the signaling cascade outlined above, BCR engagement
concurrently coordinates antigen internalization, by the process of receptor-mediated
endocytosis (Hou et al., 2006). Antigen acquisition can occur via the direct binding of free
antigen (soluble proteins of low molecular weight) by the BCR, or through the formation
of a synapse between B cells and antigen-presenting cells (APCs) displaying tethered
antigens or microorganisms (Batista, Iber, & Neuberger, 2001). Bound antigen are
internalized in a clathrin-dependent manner, and directed to multivesicular compartments
for proteolytic processing and loading onto MHC Class II molecules (Avalos & Ploegh,
2014; Cheng, Steele, Gu, Song, & Pierce, 1999). Following transport of peptide-MHC class
II (pMHCII) complexes to the cell surface, relocalization of antigen-experienced B cells is
initiated within the follicle in an EBI2 and CCR7-dependent manner (Gatto et al., 2009;
Okada et al., 2005; Rock, Benacerraf, & Abbas, 2007). Expression of CCR7, which enables
sensing of T cell-derived CCL19 and CCL21, prompts the chemotactic migration of
follicular B cells towards the boundary of the T and B cell zones, known as the
interfollicular region (Kerfoot et al., 2011; Reif et al., 2002). The interfollicular zone
subsequently becomes the stage upon which long-lived cognate interactions between
committed CD4+ Tfh cells and antigen-engaged B cells take place—interactions which
depend primarily on binding of B cell-borne pMHCII complexes with T cell receptors
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(TCR) (Kerfoot et al., 2011; Lanzavecchia, 1985; Okada et al., 2005).
High affinity recognition of pMHCII complexes by TCRs initiates a series of complex
cellular crosstalk between cognate pairs, driving subsequent cellular differentiation events.
Notably, B cell expression of the inducible co-stimulator (ICOS) ligand promotes T cell
differentiation into the Tfh phenotype (Crotty, 2014). Co-stimulation of B cells via
CD40L/CD40 interactions and T cell–secreted IL-21 results in downstream activation of
both canonical and non-canonical NFκB pathways—promoting B cell survival and
proliferation (Lu et al., 2007; Okada et al., 2005) This crosstalk ultimately induces, in a
subset of B cells, the expression of B cell lymphoma 6 (BCL-6)–widely regarded as a key
regulator of GC initiation and maintenance (Dent, Shaffer, Yu, Allman, & Staudt, 1997).

1.4.1.1

Germinal centre reactions

While plasma and memory cells have previously been shown capable of arising at
extrafollicular locations, the responding pool of high-affinity, class-switched antigenexperienced B cells is generally understood to derive predominantly from GC reactions
(Kimoto et al., 1997; Liu et al., 1996; Taylor, Pape, & Jenkins, 2012). GCs are specialized
microanatomical niches which are established by the intrafollicular seeding and clonal
expansion of activated B cells, and enable antigen-specific B cells to undergo class-switch
recombination and affinity maturation (Jacob, Kelsoe, Rajewsky, & Weiss, 1991; Liu et
al., 1996; Victora & Nussenzweig, 2012). GCs arise following the sustained formation of
cognate T and B cell interactions, resulting in the expression of the transcriptional repressor
B cell lymphoma 6 (Bcl-6) in a subset of antigen-engaged B cells and committed T
follicular helper (Tfh) cells (Dent et al., 1997). Establishment and maintenance of GCs
necessitates Bcl-6 induction in responding B cells—a process which appears to be jointly
regulated in the early stages of GC initiation by MEF2B and IRF4 (Fukuda et al., 1997;
Ochiai et al., 2013; Ying et al., 2013). Bcl-6 maintains the GC gene expression program
through both direct repression of genes promoting alternative fates (i.e. Blimp-1) and
microRNA-dependent regulation of key GC factors, such as activation-induced cytidine
deaminase (AID) (Basso et al., 2012; Crotty, Johnston, & Schoenberger, 2010; Ochiai et
al., 2013).
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The GC can be divided, on the basis of both microanatomy and function, into the dark and
light zones (DZ/LZ). Within the dark zone of the GC, rapidly cycling B cells accumulate
point mutations in the variable regions of B cell receptor (BCR)-encoding immunoglobulin
genes (Allen et al., 2004). In centroblasts, AID-mediated deamination of cytidine residues
results in a high rate of single nucleotide substitutions which, rather intuitively, seem to
cluster within complementarity-determining regions (Di Noia & Neuberger, 2007). This
stochastic process, known as somatic hypermutation (SHM), serves to diversify the range
of antigenic affinities exhibited by GC B cells, prior to their entry into the light zone for
selection (LZ). An early theory of affinity maturation, which has since found support in
recent studies, proposed that selection of GC B cells in the LZ was based upon BCR
affinities—with high affinity B cells acquiring survival signals through CD40 ligation, and
low affinity centrocytes undergoing apoptosis (Gitlin, Shulman, & Nussenzweig, 2014;
MacLennan, 1994; Shinnakasu & Kurosaki, 2017).
While expression of CXCR4 (receptor for CXCL12) maintains CD83loCD86lo centroblasts
in the DZ, a switch to cell surface expression of CXCR5 mediates their entry into the LZ,
by rendering these cells sensitive to CXCL13 chemotactic signals (Allen et al., 2004; Allen,
Okada, Tang, & Cyster, 2007). Upon their re-localization, these GC B cells become known
as centrocytes, and constitute a population of non-proliferative cells which express a
modified BCR of yet unknown antigenic affinity. The LZ of the GC is comprised of Tfh
cells and follicular dendritic cells (FDCs), which play a critical role in the selection of
centrocytes undergoing affinity maturation, and in the maintenance of the GC
microarchitecture (De Silva & Klein, 2015a). FDCs are capable of antigen capture by
means of a variety of receptors, including complement receptors CD21/35, as well as the
low-affinity Fcγ receptor CD32, which enable them to bind immune complexes [Reviewed
in (Allen & Cyster, 2008)]. In recent years, significant advances in our understanding of
Tfh cells have underscored these cells’ substantial contribution to both GC B cell selection
and the onset of memory responses (Ise et al., 2014). Within the LZ, Tfh cells provide ‘help’
to centrocytes—a catch-all term denoting an assortment of cytokine signals, such as IL-21,
along with direct cell-to-cell contact via, namely, CD40/CD40L and major
histocompatibility complex class II (MHC II)-T cell receptor (TCR) interactions (Ise et al.,
2014).
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As our understanding currently stands, centrocytes acquire antigens, which may be
displayed on FDCs, and present processed peptides to Tfh cells, in order to acquire survival
and proliferation signals. By using a delivery system allowing for dose titration of antigen
to GC B cells, Gitlin et al. demonstrated that centrocyte affinity corresponds to the
magnitude of T cell help and subsequent cycles of cell divisions in the DZ (Gitlin et al.,
2014). Entry into the LZ ultimately presents three possible outcomes for centrocytes—that
of 1) intrazonal recirculation, which subjects GC B cells to additional rounds of SHM or
CSR, 2) of apoptosis, or 3) of GC exit by means of differentiation (De Silva & Klein,
2015a).

1.4.1.2
1.4.1.2.1

Memory & effector functions
Plasmablasts and plasma cells

Plasma cells (PCs) specialize in the constitutive production and secretion of antibodies,
which promote the resolution of ongoing infections and provide a baseline layer of
protection against re-infection (Moser, Tokoyoda, Radbruch, MacLennan, & Manz, 2006).
In contrast to MBCs, which rapidly reactivate and enter a proliferative state upon secondary
antigenic exposure, PCs are post-mitotic and terminally differentiated (Moser et al., 2006).
Antibody-forming PCs are distinguishable by their surface expression of CD138
(syndecan-1), absent or low expression of common B cell markers such as CD19 and B220
and their elongated morphology, dominated by an overdeveloped endoplasmic reticulum
and golgi apparatus (Costes et al., 1999; Ribourtout & Zandecki, 2015; Wijdenes et al.,
1996). While many still consider PCs to have extinguished surface Ig expression, recent
work by Blanc and colleagues demonstrates that BM-resident IgM+ PCs, unlike their IgGproducing counterparts, retain BCR expression along with the ability to sense the presence
of their respective antigens (Blanc et al., 2016).
The term plasmablast has been used in the literature to describe both short-lived antibodysecreting cells and actively cycling plasma cell precursors (Fooksman et al., 2010; Nutt,
Hodgkin, Tarlinton, & Corcoran, 2015). These divergent definitions may lead to confusion
in the context of extrafollicular PCs, which are produced independently of GC reactions
and have a short half-life of 3 to 5 days (Ho, Lortan, MaClennan, & Khan, 1986).
Plasmablasts (PBs) and PCs are often jointly referred to under the umbrella of ‘antibody-
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secreting cells’ (ASCs). Level of cell-surface CD138, or intracellular Blimp-1 expression,
have been used as a basis of discrimination between these subsets (Shi et al., 2015). While
PBs are found in secondary lymphoid tissues, such as the splenic red pulp and lymph nodes
medullary cords, long-lived PCs take up their primary residence in the BM (Benner,
Hijmans, & Haaijman, 1981). This homing process has been shown to partially depend on
the upregulation of CXCR4, receptor for the BM stromal cell-produced CXCL12, along
with concomitant downregulation of CXCR5 and CCR7 (Hargreaves et al., 2001). Though
PC longevity remains incompletely understood, some have shown that certain BM niches
permit the interplay of PCs and eosinophils, which can provide signals to promote PC
persistence (Chu et al., 2011; Moser et al., 2006). The expression of CD138 has
additionally been shown to be important in rendering PCs sensitive to pro-survival signals,
namely IL-6 and APRIL (McCarron, Park, & Fooksman, 2017).
PB and PCs emerging from GCs are often class-switched (De Silva & Klein, 2015a). The
novel effector functions conferred by secondary isotypes serve to direct the Ab response to
various locations and against certain types of pathogens. Readily produced, yet typically
low affinity pentameric IgM molecules are particularly protective against bacteremia—due
to their ability to fix complement in circulation (Janeway, Travers, Walport, & Shlomchik,
2001). IgG and IgA antibodies are both potent neutralizers, and can easily diffuse into
bodily tissues (Vidarsson et al., 2014). The IgG subclasses constitute the most abundant
isotype found in serum, as they act to neutralize and opsonize pathogens, activate
complement, promote Ab-dependent cell-mediated cytotoxicity (ADCC), and may cross
the placental barrier to provide passive protection to the fetus (Diebolder et al., 2014;
Niewiesk, 2014; Tang et al., 2007; Vidarsson et al., 2014). Dimeric IgA can cross the
epithelium at mucosal sites, where it prevents the attachment of bacteria and the binding
of viruses, and neutralizes bacterial toxins (Apter, Lencer, Finkelstein, Mekalanos, &
Neutra, 1993). Though the function of IgE antibodies are notoriously linked to the allergic
response, their ability to elicit mast cell degranulation to trigger a range of expulsive
responses renders them protective against helminth infections (Fitzsimmons, Falcone, &
Dunne, 2014).
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1.4.1.2.2

Memory B cells

During primary immune responses, the establishment of mature GCs in lymphoid follicles
may take up to seven days (De Silva & Klein, 2015a). This period of delay between first
antigen encounter and antibody production is owed partly to the many required processes
leading up to the induction of adaptive immune responses—including those of dendritic
cell (DC) maturation and migration, T cell activation, T-B cell cognate interactions and
eventually seeding of the lymphoid follicle by Bcl6-expressing B and T cells (Parham,
2015). By contrast, subsequent exposures to a given immunogen are known to more rapidly
give rise to high affinity antibodies of class-switched isotypes (Ahmed & Gray, 1996). This
important property of adaptive immune responses is attributable to a population of longlived, ‘rapid responder’ MBCs generated during a primary response (Kurosaki et al., 2015).
The body of knowledge regarding MBCs has long been dominated by the study of human
MBCs, which have classically been identified by their cell-surface expression of CD27 and
IgD (Agematsu et al., 1997). Transcriptomic comparisons of naïve and memory B cells
have highlighted many similarities between these subsets, but have failed to identify
transcription factors involved in driving memory identity (Good & Tangye, 2007;
Tomayko et al., 2008). The identification of murine MBCs must thus rely on established
functional characteristics—namely, their metabolic quiescence, antigen-experienced
status, persistence and ability to generate secondary antibody-forming responses upon rechallenge, following adoptive transfer (MaClennan & Gray, 1986; Suan, Kräutler, et al.,
2017; Zuccarino-Catania & Shlomchik, 2015). Surrogate phenotypic markers—such as
evidence of class-switching (IgG1+), exclusion of GC cells and PCs, and model antigen
specificity—are employed experimentally in defining cells which have acquired a memory
phenotype (Weisel, Zuccarino-Catania, Chikina, & Shlomchik, 2016). The use of such
markers, however, generally precludes the analysis of pre-existing (non-model antigen
specific) or non-class-switched (IgM+) MBCs (Dell, Lu, & Claflin, 1989).
Despite the prevalent view that the differentiation of GC B cells is a dichotomous decision
between effector and memory fates, the factors governing the generation of MBCs remain
elusive (Suan, Sundling, & Brink, 2017). At the level of transcriptional regulation,
induction of the transcription factor Bach2 has been shown to play a critical role in the
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generation of MBCs (Ochiai et al., 2006; Shinnakasu & Kurosaki, 2017). Multiple reports
have outlined a role for BCR affinity in influencing the differentiation of PCs and MBCs,
by demonstrating a bias of high-affinity cells in the PC pool and of low-affinity cells in the
MBC compartment (Kräutler et al., 2017; Phan et al., 2006; Shinnakasu et al., 2016). The
enrichment of somatic mutations observed in the PC compartment, relative to the longlived MBC fraction, is supported by work by Weisel and colleagues, which suggests that
memory B cells arise as early by-products of GC reactions (Weisel et al., 2016). Recent
work by Suan and colleagues has identified a population of CCR6-expressing MBC
precursors within the LZ of the GC (Suan, Sundling, et al., 2017). These MBC precursors
were found to be a quiescent population carrying a relatively low burden of mutations
within VDJ loci—further supporting a model of low-affinity GC B cell-derived MBCs
(Suan, Sundling, et al., 2017). Expression of CCR6 appears to be of functional relevance
within MBC compartment, as its loss incurs defects in secondary antibody-forming
responses and alters the localization of these cells in the spleen (Elgueta et al., 2009).

1.4.2

T cell-independent responses

T cell-dependent B cell responses are generally mounted against protein antigens, owing
to MHC restriction in T cells (Parham, 2015). However, certain B cells subsets, namely
comprising the B-1 and MZ compartments, do not require T cell assistance in completing
their activation, and in inducing their differentiation into antibody-secreting cells. These T
cell-independent (TI) responses, otherwise known as thymus-independent, can be
generated against two primary classes of antigens, denoted as TI-1 and TI-2. TI-1 antigens
are mitogens capable of inducing B cell activation without need for direct interactions with
the BCR, such as LPS (Jeurissen, Ceuppens, & Bossuyt, 2004). TI-1 antigens are
polyclonal, as they can induce activation irrespective of BCR specificity (Jeurissen et al.,
2004). By contrast, TI-2 antigens are comprised of repetitive, multivalent structures which
can induce BCR crosslinking, resulting in potent BCR signalling and activation in the
absence of T cell help (Mond et al., 1995). The model antigen ficoll (which may be
haptenated), along with numerous bacterial capsular polysaccharides, stand as prototypic
examples of TI-2 antigens. The stimulatory capacities TI-2 antigens can be potentiated by
cytokines, such as interferon-γ (Mond et al., 1995).
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For many years, TI B cell responses were believed to be incompatible with the generation
of memory—prompting the development of glycoconjugate vaccines against pathogens
such as Haemophilus influenzae type B and Neisseria miningitidis (Goldblatt, 2000). These
vaccines capitalized on the concept of linked recognition, whereby a weak polysaccharide
immunogen is conjugated to an immunogenic protein antigen (Goldblatt, 2000).
Polysaccharide-specific B cells can thus bind and internalize the conjugated molecule, and
present peptides to obtain T cell help (Parham, 2015). Some reports, however, have
indicated that TI memory cells can indeed be formed following exposure to TI antigens
(Alugupalli et al., 2004; Obukhanych & Nussenzweig, 2006). Though these TI MBCs
present phenotypic differences relative to their T cell-dependent counterparts, they appear
to be of similar longevity and can be class-switched (Obukhanych & Nussenzweig, 2006).

1.5 Transcriptional regulation in B cells
1.5.1

E26-transformation specific transcription factors

The E26-transformation specific (Ets) family of transcription factors is comprised of over
20 members in mice—so categorized on the basis of their shared ‘Ets’ DNA-binding
domain (Bult et al., 2008; Foos & Hauser, 2004). This Ets DNA-binding domain, first
identified as belonging to a protein of the avian leukemia retrovirus E26, enables DNAprotein interactions via a helix-turn-helix motif (Hollenhorst, McIntosh, & Graves, 2011).
Ets factors share a high affinity for consensus 5’-GGA(A/T)-3’ sequences, upon which
they may act as transcriptional activators or repressors (Oikawa & Yamada, 2003). The
expression of Ets family members in many mammalian species, tissues types has been the
subject of extensive characterization [Reviewed in (Oikawa & Yamada, 2003)]. While the
expression of some Ets factors is near ubiquitous, certain members exhibit more lineagerestricted patterns—as is the case for factors of the SPI subfamily, discussed in the
following sections (Hollenhorst et al., 2011).

1.5.1.1

PU.1 and Spi-B

The highly-related Ets transcription factors PU.1 (Spi1) and Spi-B (Spib) have widely been
implicated in the differentiation and function of the myeloid and lymphoid lineages
(McKercher et al., 1996; Scott et al., 1997; Scott, Simon, Anastasi, & Singh, 1994). PU.1
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and Spi-B exhibit an extensive degree of structural similarity, owing to their 43% shared
amino acids (Ray et al., 1992). Like other members of the Ets family, PU.1 and Spi-B can
interact with the purine rich, core PU-box (GGAA/T) motif as monomers, or can recruit
co-factors to activate transcription of their target genes (Sharrocks, 2001). Recruitment of
the well-characterized PU.1 binding partner interferon regulatory factor 4 (IRF-4, also
known as Pip) at ETS-IRF composite elements (EICE) occurs following the
phosphorylation of serine residues in the proline, glutamine, serine and threonine (PEST)
region of PU.1 and Spi-B (Perkel & Atchison, 1998). While early studies had suggested
the binding specificities of PU.1 and Spi-B to be identical, genome-wide approaches have
revealed sites bound uniquely by one factor or the other, despite an extensive overlap in
occupancy patterns (Solomon, Li, Piskorz, Xu, & DeKoter, 2015).
With over 110 gene targets identified to date, PU.1 acts as an activator of transcription for
several genes and microRNAs, including the macrophage colony-stimulating factor (MCSF), IgH and IgL loci [Reviewed in (Turkistany & Dekoter, 2011)]. PU.1 expression
levels have a dramatic impact on the differentiation of early hematopoetic progenitors—
with high levels of PU.1 promoting myeloid differentiation in lymphoid-myeloid
progenitors, and low PU.1 levels favoring the B lymphocytic fate in the BM (DeKoter &
Singh, 2000). By contrast, Spi-B expression is restricted primarily to the B lymphoid
lineage, in which it coordinates the induction of genes involved in BCR signalling, such as
that of Blnk, Syk and Grap2 (Bednarski et al., 2016; Garrett-Sinha et al., 2005). In addition
to being detected at high levels in B cells, Spi-B expression has been implicated in
plasmacytoid DC development (Schotte et al., 2003; Su et al., 1996, 1997).
Despite their highly homologous structures and numerous functional redundancies, the
expression of Spi-B cannot compensate for a lack of PU.1. Independently-generated mouse
strains homozygous for non-functional alleles of PU.1 (Sfpi-/-) die during gestational
development, or immediately postnatally, and fail to generate B cells and macrophages
(McKercher et al., 1996; Scott et al., 1994). By contrast, Spi-B knockout mice are able to
generate mature B cells capable of mounting normal antibody-forming responses,
following T cell-dependent immunization (Su et al., 1997). The lack of impairment in
primary reponses to T cell-dependent antigenic challenge is rather remarkable, considering
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the reductions observed in both the frequencies and numbers of FO B cells in Spib-/- spleens
(Li, Solomon, Fulkerson, & DeKoter, 2015). Despite their ability to generate functional
primary responses, Spib-/- B cells exhibit proliferation defects in response to BCR
stimulation—a defect compounded in Sfpi+/-Spib-/- B cells, which harbour a complete
deficiency of Spi-B combined with heterozygous loss of PU.1 (Garrett-Sinha et al., 1999;
Li et al., 2015; Su et al., 1997). Su et al. have further reported impairments in Spib-/secondary antibody-forming responses, namely with regards to decreased IgG1, IgG2a/c and
IgG2b titres, following prime and boost immunization with haptenated model antigens.
Correspondingly, Spib-/- mice were shown to have poorly sustained splenic GCs 28 days
post-immunization (d.p.i.), relative to WT mice (Su et al., 1997). This phenotype was
exacerbated in Sfpi1+/-Spib-/- mice, which failed to generate splenic GCs at 10 or 28 d.p.i.
(Garrett-Sinha et al., 1999).
Multiple lines of evidence converge to suggest that the transcriptional regulation exerted
by PU.1 and Spi-B suppresses the plasmacytic potential of activated B cells (Carotta et al.,
2014; Schmidlin et al., 2008; Willis et al., 2017). By forming ternary complexes with EICE,
IRF4/8-Ets dimers can directly enforce gene expression programs corresponding to either
the GC or plasmacytic fates. The IRF8-PU.1 complex has previously been shown to be
instrumental in maintaining the activated B cell program—with a loss of both IRF8 and
PU.1 leading to markedly increased ASC differentiation following stimulation with
CD40L and IL-4 (Carotta et al., 2014; Xu et al., 2015). Both PU.1 and Spi-B have been
shown to be downregulated in splenic and bone marrow-derived ASCs—with Spi-B
showing a rather marked decline in expression during the transition from GC B cells to
splenic ASCs (Carotta et al., 2014). Concurrent and progressive loss of EICE accessibility
over successive cell divisions further extinguishes PU.1 and Spi-B-mediated regulation in
activated B cells (Scharer, Barwick, Guo, Bally, & Boss, 2018). A recent publication by
Willis et al. demonstrates that loss of PU.1 and Spi-B in activated B cells results in derepression of PC differentiation, and corresponds to an upregulation of Prdm1, Xbp1 and
Aicda (Willis et al., 2017). Schmidlin and colleagues have additionally reported that
ectopic Spi-B overexpression in human B cells impairs CD138+ plasma cell generation,
and corresponds with decreased expression of BLIMP-1 and XBP-1 (Schmidlin et al.,
2008).
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1.5.1.2

Spi-C

Following its isolation by two independent research groups in 1999, Spi-C (previously
known as PU.1-related factor, or Prf) was characterized as a PU.1-related protein based on
sequence homology and similarities in binding interactions with the PU-box motif
(Bemark, Mårtensson, Liberg, & Leanderson, 1999; Hashimoto et al., 1999). The Ets
DNA-BD of Spi-C exhibits 57% and 61% sequence homology with that of PU.1 and SpiB, respectively (Hashimoto et al., 1999). In early studies, Spi-C expression was
demonstrated to be primarily restricted to the B cell compartment—namely in pre-B and
mature B cells—though some expression was also detected in red pulp macrophages
(Bemark et al., 1999; Hashimoto et al., 1999). Spi-C expression was later shown to differ
in peritoneal and splenic CD5+ B-1a cells—being overexpressed in the latter—and was
shown to be expressed at high levels in red pulp macrophages (Stoermann, Kretschmer,
Düber, & Weiss, 2007). From a structural standpoint, and similarly to PU.1 and Spi-B, SpiC contains an N-terminus transactivation domain. Interestingly, the transactivation domain
in Spi-C does not allow for IRF4 binding, as demonstrated by gel-shift analysis (Carlsson,
Persson, & Leanderson, 2003).
The role of Spi-C as a potential antagonist of PU.1, first suggested by Hashimoto et al.,
was later corroborated by several reports (Hashimoto et al., 1999). Schweitzer and
colleagues demonstrated that Spi-C, like PU.1, is able to bind at sites within the IgH
intronic enhancer and FcγRIIb promoter in progenitor B cells. At these sites, however, SpiC was shown to oppose the function of PU.1—resulting in increased sterile transcripts of
IgH and decreased transcription of FcγRIIb, which encodes the inhibitory Fc receptor
(Schweitzer et al., 2006). Ectopic expression of Spi-C in pro-B cells induced upregulation
of CD25 and downregulation of c-Kit—changes which are consistent with a pre-B cell-like
phenotype (Schweitzer et al., 2006). Zhu and colleagues successfully generated a
transgenic mouse strain in which Spi-C expression is maintained under the control of the
IgH intronic enhancer (Eµ). B cell-specific Spi-C overexpression of 2-5 fold was sufficient
to result in a decrease of BM and splenic CD19+B220+ B cell frequencies, along with
reductions in the numbers of T1, T2, T3, MZ and FO B cells (Zhu, Schweitzer, Romer,
Sulentic, & DeKoter, 2008). Splenic B cells obtained from Spi-C transgenic animals
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showed marked proliferation defects in response to stimulation with CD40 or via the BCR.
Further, immunization of Eµ-SpiC transgenic mice with haptenated keyhole-limpet
hemocyanin resulted in a two-fold increase in IgM and two-fold decrease in IgG titres, as
compared to WT mice (Zhu et al., 2008). These findings were the first to suggest a potential
role for Spi-C in the generation of antibody-forming responses during infection, or
following immunization (Zhu et al., 2008).
Despite its antagonistic functions, Spi-C has been shown capable of complementing PU.1
and Spi-B transcriptional activation at certain loci in B cells. Using Sfp1+/- Spib-/- (PUB)
mice, DeKoter et al. reported that reductions in CD23+ FO B and T2 cell frequencies could
be rescued by transgenic Spi-C expression in Eµ-Spi-C+ PUB mice (DeKoter et al., 2010).
Spi-C was shown to directly activate transcription at the FcεR2a locus, which encodes the
cell-surface marker CD23 (DeKoter et al., 2010). To further investigate the regulatory role
of Spi-C in B cell development, a Spib-/-Spic+/- mouse strain was generated by Li and
colleagues (Li et al., 2015). While concurrent loss of Spi-B and Spi-C (Spib-/-Spic-/-) proved
to be non-viable, Spi-C heterozygosity on a Spib-/- background was shown to rescue
reductions in both frequencies and absolute numbers of splenic FO and T2 B cells, which
were observed in Spib-/- mice. A deficiency in Spi-C additionally rescued proliferation of
Spib-/- B cells following stimulation by LPS or anti-IgM—a rescue mediated in part by
restored Nfkb1 expression in Spib-/-Spic+/- mice. Spi-C was demonstrated as capable of
binding the Nfkb1 locus, but unlike Spi-B, was unable to activate transcription at this site
(Li et al., 2015).
A recent study by Bednarski et al. showed that Spi-C expression is induced in pre-B cells,
following the RAG-dependent generation of DNA double-stranded breaks (Bednarski et
al., 2016). At this stage in B cell development, Spi-C binds regulatory regions of Syk and
Blnk, where it repressed transcription (Bednarski et al., 2016). By blocking the
transcription of key proteins involved pre-BCR signal transduction, Spi-C was shown
capable of suppressing pre-BCR-mediated proliferation—in a likely attempt to promote
cell cycle arrest at the small pre-B cell stage, which is marked by genomic instability arising
from recombination (Bednarski et al., 2016). The above studies demonstrate the potential
for Spi-C to act as both activator and transcription during early B cell development. Based
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on its documented involvement in the regulation of pre-BCR and BCR signaling, Spi-C
might feasibly be implicated in B cell fate determination at several distinct stages—
between the FO and MZ B cell subsets, or during activated B cell fate decisions between
PCs or MBCs (Bednarski et al., 2016; Pillai & Cariappa, 2009; Zhu et al., 2008). As of yet,
patterns of Spi-C expression throughout B cell development remain to be characterized.
The function of the Spi-C in regulating B cell developmental programs during immune
responses is entirely unknown.

1.5.2

Activated B cell fate decisions

In the GC, activated B cells must dynamically balance the pull of three opposing states:
that of the inherently transient GC fate, that of the effector plasma cell (PC) fate, and
finally, that of the sentinel-like memory B cell (MBC) fate. B cell exit from the GC thus
necessitates the halting of intrazonal recirculation, followed by differentiation into PCs or
MBCs. The molecular determinants responsible for orchestrating activated B cell fate
commitment and regulating GC exit have become the focus of intense scrutiny (Tarlinton,
2012). Two preeminent perspectives on the issue—the stochastic and instructive models of
activated B cell fate decisions—are discussed below.
Under the stochastic model of fate determination, GC B cells face a decision with every
cellular division—to differentiate, to remain in the GC for further rounds of SHM and CSR,
or to die—resulting in a collective probability for certain cells to undergo differentiation at
any given time (Duffy et al., 2012; Good-Jacobson & Shlomchik, 2010). Within this
framework, the influence of intrinsic factors, such as expression levels of key transcription
factors, or extrinsic factors, such as the magnitude of T cell help, are resolved internally
and autonomously for each B cell (Duffy et al., 2012; Hawkins, Turner, Dowling, van
Gend, & Hodgkin, 2007; Tarlinton, 2012). Work in support of this model has shown that,
while on an individual cellular level, time to division, to fate commitment or death is highly
changeable, population level outcomes remain steady and resistant to variations across
responses (Duffy et al., 2012). Mathematical models based on the stochastic framework,
devised by Phil Hodgkin’s group, have shown promise in predicting the survival and
division of stimulated B cells in vitro (Hawkins, Markham, McGuinness, & Hodgkin,
2009; Hawkins et al., 2007).
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In opposition to the stochastic framework of differentiation stands the instructive model,
under which B cell fate determination primarily depends on extrinsic, Tfh-derived
‘instructions’ (Tarlinton, 2012). In recent years, an affinity-driven model of activationinduced B cell fate decisions has gained traction in the literature (Paus et al., 2006). In this
model, commitment to the PC fate is initiated in high affinity, LZ-resident B cells, and is
dependent upon signals from Tfh cells (Kräutler et al., 2017; Paus et al., 2006). Work by
Shinnakasu and colleagues has suggested that high affinity B cells receive correspondingly
strong T cell help, which promotes the PC fate via downregulation of the transcriptional
repressor Bach2 (Shinnakasu et al., 2016). Similarly, strong T cell help has been shown to
result in the degradation of Cbl ubiquitin ligase—leading to de-repression of IRF4 and PC
differentiation (Li et al., 2018). Ultimately, the instructive model seems intuitive, in that
the long-lived and post-mitotic PC compartment is given priority in terms of high-affinity
cells. MBCs, which are bound to re-establish secondary GCs upon reactivation, need only
to remain able to bind their antigen—and can therefore bear BCRs of relative lesser affinity
(Kurosaki et al., 2015).

1.5.2.1

Blimp-1 & Bcl6

The gene regulatory network comprised of Blimp-1 and Bcl-6 has long been known to play
a critical role in the tug-of-war of gene expression between the GC B cell and PC fates.
These transcription factors are widely viewed as exerting opposing pressures on activated
B cells—with Bcl-6 maintaining the GC gene expression program, and Blimp-1 promoting
terminal differentiation of B cells into antibody-secreting cells (ASCs) (Shaffer et al.,
2002).
Blimp-1, or B lymphocyte-induced maturation protein-1 (encoded by Prdm1), is a C2H2type zinc finger transcriptional repressor which has been identified as a master regulator of
terminal B cell differentiation (Keller & Maniatis, 1992; Turner, Mack, & Davis, 1994).
Early work showed that expression of Blimp-1 was restricted to the activated B cell and
PC compartment, and was activated early in the process of differentiation from B cells to
ASCs (Angelin-Duclos, Cattoretti, Lin, & Calame, 2000; Turner et al., 1994). Ectopic
expression of Blimp-1 in lymphoma cells resulted in increased cell size, Ig secretion and
expression of CD138—important features of the PC phenotype (Turner et al., 1994).
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Blimp-1 has since been shown to directly repress Myc, thus arresting intrazonal
recirculation in the GC, along with Pax5 and MHC class II transactivator (CIITA), which
coordinates the silencing of B cell gene expression patterns (Lin, Angelin-Duclos, Kuo, &
Calame, 2002; Lin, Wong, & Calame, 1997; Piskurich et al., 2000). PC differentiation is
further supported by the indirect induction of Xbp-1 by Blimp-1, which is thought to
promote antibody synthesis and secretion via regulation of the unfolded protein response
(Tellier et al., 2016). Of note, Blimp-1 has additionally been shown to repress Spi-B, which
acts as a negative regulator of plasma cell differentiation (Schmidlin et al., 2008; Shaffer
et al., 2002). While germline knockouts of Blimp-1 are non-viable, a conditional model of
Blimp-1 deletion in CD19-expressing mature B cells showed that Prdm1-/- mice exhibit
profound defects in the PC compartment—in terms of both PC frequencies and Ig titers
following immunization (Shapiro-Shelef et al., 2003).
By contrast, the generation and maintenance of GCs necessitates Bcl-6 expression (Crotty
et al., 2010; Dent et al., 1997; Fukuda et al., 1997). Similarly to Blimp-1, B cell lymphoma6 (encoded by Bcl6) is a Krüppel-type zinc finger-containing transcriptional repressor. First
identified through its implication in diffuse large B cell lymphoma, Bcl6 is expressed at
high levels in GC B cells and Tfh cells to promote their survival and proliferation (Crotty
et al., 2010; Ye et al., 1993). Though the mention of Bcl6 seems for many intrinsically
linked to the GC, the factor plays an important role in early B cell development
(Swaminathan, Duy, & Müschen, 2014). In GC B cells, Bcl6 directly represses Prdm1, and
drives the processes of SHM and CSR through its indirect induction of AID (encoded by
Aicda) (Basso et al., 2012; Toyama et al., 2002). Conditional deletion of Bcl6 in
lymphocytes leads to humoral responses in which MBCs can be produced, despite a
complete lack of GCs, and severe defects in the generation of long-lived PCs are observed
(Toyama et al., 2002).

1.5.2.2

IRF4 & IRF8

The interferon regulatory factors 4 and 8 (IRF4 / IRF8) are related transcription factors
belonging to the IRF superfamily which bind, by virtue of their tryptophan-rich helix-turnhelix DNA binding domain, to conserved IFN-stimulated response elements (ISRE)
(Yanai, Negishi, & Taniguchi, 2012). Both IRF4 and IRF8 have shown to be capable of
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homodimerization and heterodimerization with other IRF factors and Ets family members
(Shukla & Lu, 2014). The diverse range of potential protein-protein interactions involving
IRF4 and IRF8 likely contributes to their numerous functions in B cells—including early
B cell development, tolerance induction and ultimately fate commitment (Lu, Medina,
Lancki, & Singh, 2003; Pathak, Ma, Trinh, & Lu, 2008; Xu et al., 2015).
More recently, Harinder Singh’s group has identified an important role for the IRF4 and 8
in governing the fate of activated B cells in a concentration-dependent manner (Xu et al.,
2015). High abundance of IRF4 (paired with low levels of IRF8 expression) favours the
generation of PBs and PCs, while high IRF8 and correspondingly low IRF4 expression
favour the GC fate (Xu et al., 2015). This study supports previous reports regarding the
importance of graded IRF4 expression in antigen-experienced B cells. High level IRF4
induction immediately following B cell activation are necessary for the establishment of
GCs (Willis et al., 2014).
Interactions between IRF and Ets factors have long been documented (Eisenbeis, Singh, &
Storb, 1995). By forming ternary complexes with ETS-IRF composite elements (EICE),
IRF4/8-Ets dimers can directly enforce gene expression programs corresponding to either
the GC or plasmacytic fates. The IRF8-PU.1 complex has previously been shown to be
instrumental in maintaining the activated B cell program—with a loss of both IRF8 and
PU.1 leading to markedly increased ASC differentiation following stimulation with
CD40L and IL-4 (Carotta et al., 2014; Xu et al., 2015). The ability of PU.1 and Spi-B to
interact with both IRF4 and IRF8 in order govern activation-induced B cell decisions seems
somewhat paradoxical, given reports of PU.1 and Spi-B acting as negative regulators of
plasma cell differentiation (Carotta et al., 2014; Schmidlin et al., 2008). Both PU.1 and
Spi-B have been shown to be downregulated in splenic and bone marrow-derived ASCs—
with Spi-B showing a rather marked decline in expression during the transition from GC
B cells to splenic ASCs (Carotta et al., 2014). The reductions in PU.1 and Spi-B expression
seem to correspond with periods of dominant IRF4 expression in B cells, and may thus fit
with the dominantly negative regulatory effect exerted by the Ets factors during activated
B cell fate decisions. Thus, PU.1 and Spi-B may be preferentially co-opted during periods
of high IRF8 expression, owing at least partly to the factors’ shared expression profile.
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1.5.2.3

Bach2

The related BTB Domain and CNC Homology 1 and 2 (Bach1/Bach2) factors belong to
the basic region leucine zipper (bZIP) family of transcription factors (Oyake et al., 1996).
As members of the bZIP family, Bach1 and Bach2 exert regulatory influence over target
Maf recognition elements (MAREs) by dimerically binding TGA(G/C)TCA motifs via
their conserved leucine zipper domains (Igarashi, Kurosaki, & Roychoudhuri, 2017;
Reinke, Baek, Ashenberg, & Keating, 2013). From a structural standpoint, the Bach
proteins share an N-terminus broad-complex, tramtrack and bric-à-brac (BTB) domain,
though Bach2 alone possesses an intrinsically disordered region, located between its bZIP
and BTB domains (Igarashi et al., 2017). Bach2 has further been shown capable of
interacting with target sequences as a homodimer, while Bach1 must heterodimerize with
proteins of the MAF family to bind DNA (Oyake et al., 1996). Since their identification,
and despite these modest structural differences, the Bach factors have primarily been
characterized as transcriptional repressors (Oyake et al., 1996). Within the immune
compartment, Bach1 is highly expressed in myeloid-lineage cells, while Bach2 exhibits
lymphoid-restricted expression patterns (Heng, Painter, & Consortium, 2008).
In recent years, a number of reports have implicated Bach2 in the regulation of early B cell
development, and cellular fate decisions during immune responses (Kometani et al., 2013;
Sidwell & Kallies, 2016; Ye & Mai, 2013). Mice lacking both Bach factors harbour marked
defects in B lymphopoiesis, and exhibit increased myelopoiesis (Itoh-Nakadai et al., 2014).
These defects have been partly attributed to loss of Bach2-mediated repression of myeloidassociated genes, such as Cebpb and Ly96, along with Spic (Itoh-Nakadai et al., 2014).
Early reports have demonstrated that Bach2 expression in early B cell precursors allows
repression of premature Ig heavy chain transcription during development (Muto et al.,
1998). In pre-B cells, Bach2 critically opposes the action of Bcl6 during negative
selection—with Bach2 expression enabling the removal of pre-B cells bearing nonproductive heavy chain rearrangements (Swaminathan et al., 2013).
Following B cell maturation and activation, Bach2 has been shown to play an important
role in the processes of CSR and SHM (Muto et al., 2004). Upon T cell-dependent
immunization, Bach2-/- mice lacked GCs, exhibited impaired class-switching to IgG1 and a
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minimal high affinity-conferring mutations in CDRs (Muto et al., 2004). The lack of GC
establishment was linked, in a later report, to accelerated differentiation of Bach2-/- splenic
B cells into IgM-producing PCs, due to loss of Bach2-mediated repression of Prdm1 (Muto
et al., 2010; Ochiai et al., 2006). In vitro studies have suggested that synergistic corepression of Blimp-1 by Bach2 and Bcl6, potentially driven by direct interactions between
the factors, plays an important role in maintaining the identity of activated B cells (Ochiai,
Muto, Tanaka, Takahashi, & Igarashi, 2008).
In addition to delaying plasma cell differentiation, allowing sufficient time for GC B cells
to undergo CSR and SHM, Bach2 has been implicated in the generation of immunological
memory in B and T cells (Roychoudhuri et al., 2016; Shinnakasu et al., 2016). Loss of
Bach2 was shown to lead to reductions in the memory B cell pool, independently of Blimp1 transcriptional repression (Shinnakasu et al., 2016). High levels of Bach2 expression in
GC B cells, likely the result of relatively weak T cell help, has been posited to promote
their differentiation into MBCs (Shinnakasu et al., 2016). These findings suggest that
Bach2 constitutes a key regulator in the affinity-based model of activated B cell fate
decisions—a model in which high-affinity cells are predisposed to enter the PC
compartment, while cells of lesser affinity have an increased probability of differentiating
into MBCs (Phan et al., 2006).

1.6 Hypothesis & Specific Aims
The governing hypothesis underlying the present study is that Spi-C opposes the function
of related Ets transcription factors PU.1 and Spi-B during B cell antibody-forming
responses to T cell-dependent antigens. As such, and based on available literature
suggesting a negative regulatory role for Spi-B in PC differentiation, we specifically
hypothesize that:
I.

The impaired secondary IgG1, IgG2a/c and IgG2b responses observed by Su et al. in
Spib-/- mice will be rescued in Spib-/- Spic+/- mice (Su et al., 1997).

II.

The defects in secondary responses exhibited by Spib-/- animals stem from an
increased propensity of B cells for premature differentiation into PCs, at the
putative expense of MBCs. We predict that Spi-C heterozygosity on a Spib-/background will result in decreased PC generation, compared to Spib-/- B cells.
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III.

Loss of Spi-B alters the transcriptional profile of activated B cells, predisposing
them to take on a PC phenotype, while concurrent loss of Spi-C will promote the
maintenance of B cell identity.

In keeping with the specific hypotheses outlined above, the following research aims are
proposed:
i. To characterize the impact of Spi-C heterozygosity on antibody-forming
responses, following immunization with T cell-dependent model antigen NPOVA in Spib-/- mice.
ii. To investigate the respective capacities of Spib-/- and Spib-/- Spic+/- B cells to
differentiate into CD138+ antibody-secreting cells (ASCs), under ex vivo
conditions which promote PC differentiation.
iii. To identify a candidate gene for joint regulation by Spi-B and Spi-C, which has
been implicated in the fate determination of activated B cells.
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2

Chapter 2: Methods

2.1 Mice
Spib-/- and Spib-/-Spic+/- mice were generated as previously described (Li et al., 2015).
C57BL/6 (WT) mice were purchased from Charles River Laboratories (Pointe-Claire, QC,
Canada). All animals were housed under specific pathogen-free conditions at the West
Valley facility (London, ON), and were monitored in accordance with an animal use
protocol approved by the Western University Council on Animal Care. Genotyping was
performed by PCR, as previously described, using the primers outlined in Table 1 (DeKoter
et al., 2010; Kohyama et al., 2009).

2.2 Cell culture
Mouse 39B9 pre-B cells were cultured in RPMI-1640 medium (Wisent, St-Bruno, Qc,
Canada) supplemented with 10% bovine serum, 5 mg/mL penicillin/streptomycin/Lglutamine, and 5 x 10-5 M β-mercaptoethanol (βME). Primary B cells were cultured in
complete RPMI-1640, requiring 10% fetal bovine serum, 5 x 10-5 M βME, 0.01 M HEPES,
10 units penicillin/1 mg/mL streptomycin/20 mM L-glutamine, 10 mM sodium pyruvate,
1 mM MEM non-essential amino acids (ThermoFisher Scientific, Rochester, NY). Cells
were cultured under the following conditions: 37°C at 5% CO2.

2.3 T cell-dependent immunizations
Six to eight week-old mice were immunized intraperitoneally with 100 ug of NP15-OVA
or NP17-OVA (Biosearch Technologies, Novato, CA) adjuvanted with 50% (vol/vol) of
Imject™ alum (ThermoFisher Scientific, Rochester, NY). For experiments involving
secondary responses, mice were re-immunized on day 30 following the primary challenge
with a boosting dose identical to that of the prime.

2.4 ELISpot assay
Frequencies of NP-specific antibody-secreting cells (ASCs) per 106 splenocytes were
determined using the ELISpot assay on Immunolon Microtiter 4 HBX plates
(ThermoFisher Scientific, Rochester, NY). Following spleen excision, single cellsuspensions were obtained using frosted glass slides and filtered through a fine nylon mesh

29

(Component Supply Company, Sparta, TN) Splenocytes were red blood cell (RBC)depleted by ammonium-chloride-potassium (ACK) lysis, washed in MACS buffer (10%
fraction V fetal bovine serum (FBS), 5% EDTA in PBS) and counted using the Moxi Z
Mini Automated Cell Counter (Orflo, Ketchum, ID). Splenocytes were serially diluted in
triplicate from a starting concentration of 1 x 106 cells per 300 µl, and incubated in NPKLH-coated wells (Biosearch Technologies, Novato, CA) for 5 hours at 37°C (5% CO2)
in 10% FBS-containing RPMI 1640. Alkaline phosphatase (AP)-conjugated goat antimouse IgM (1:1500) (Mabtech AB, Sweden), IgG1, IgG2b and IgG2c (1:2500) (Jackson
Immunoresearch, Westgrove, PA) were incubated overnight in corresponding wells. The
5-bromo-4-chloro-3-indolyl-phosphate (BCIP, Sigma-Aldrich, St. Louis, MO) substrate in
3% low-melt agarose gel (NuSieve™ GTG Agarose, Lonza), diluted in Tris/NaCl solution
(Tris 100 mM, NaCl 100 mM, MgCl2 5 mM, pH 9.5), were used to develop spots. Plates
were imaged using the ImmunoSpot® S6 Analyzer, and counted using the ImmunoSpot®
software (Cellular Technology Limited (CTL), Cleveland, OH). Spot counts from triplicate
wells in individual mice were averaged, then plotted against the corresponding dilution for
each antibody. Logarithmic regressions were performed in Excel using built-in functions,
and curves of best fit were used to calculate adjusted frequencies of ASCs per 1 x 106 cells.

2.5 Flow cytometry
Following spleen excision, single cell-suspensions were obtained using frosted glass slides
and filtered through a fine nylon mesh (Component Supply Company, Sparta, TN).
Samples were RBC-depleted by ammonium-chloride-potassium (ACK) lysis, then washed
in MACS buffer and counted using the Moxi Z Mini Automated Cell Counter (Orflo,
Ketchum, ID). Anti-Fc-γ receptor blocking was performed using purified purified rat antimouse CD16/CD32 (BD Bioscience, Franklin Lakes, NJ). Cell-surface staining was
performed using the following antibodies at a concentration of 1:100 in MACS buffer,
purchased from eBioscience (San Diego, CA), BD Bioscience (Franklin Lakes, NJ) or
Biolegend (San Diego, CA): Brilliant Violet 421- and allophycocyanin-conjugated antiCD45R/B220 (Ra3-6B2), biotin- and phycoerythrin (PE)-conjugated anti-CD138 (281-2),
PE- and fluorescein (FITC)-conjugated CD19 (6D5), and PE-conjugated streptavidin.
Live/dead staining was performed using the Fixable Viability Dye eFluor 506
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(eBioscience, San Diego, CA) according to manufacturer’s instructions. Samples were run
at the London Regional Flow Cytometry Facility on a FACSCanto SORP (BD
Biosciences), and acquired using FACSDiva (Version 8.0.1). Analysis was performed
using the FlowJo software (TreeStar, Ashland, OR) (Version 10.4.2).

2.6 B cell enrichment & ex vivo plasma cell generation assay
Spleens were harvested from male mice aged 6-10 weeks and gently ground into a singlecell suspension using frosted glass slides, as described above. Following RBC depletion by
hypotonic lysis, B cells were enriched by negative selection using the Miltenyi system—
comprised of the VarioMACS magnet, LD depletion columns, streptavidin microbeads
(Miltenyi Biotec, Germany) and biotin-conjugated mouse anti-CD43 (clone: S7).
Following enrichment, B cells were stained using the CellTrace Violet Cell Proliferation
Kit (ThermoFisher Scientific, Rochester, NY) at a concentration of 1.5 µM. Enriched,
CellTrace-stained B cells were plated (1 x 105 / well) in 96-well plates under modest
(recombinant murine IL-4 and CD40L (1:1000), R&D Systems, Minneapolis, NE), potent
(recombinant murine IL-4, IL-5 and CD40L (1:1000), R&D Systems, Minneapolis, NE) or
no stimulation conditions in complete RPMI-1640. At days 4 and 5 of culture, the cells
were stained using PE-conjugated anti-CD138 and APC-conjugated B220 (1:100) along
with Fixable Viability Dye eFluor 506 (eBioscience, San Diego, CA) and assessed on the
BD FACS Canto (BD Biosciences, San Jose, CA, USA) instrument at the London Regional
Flow Cytometry Facility.

2.7 Reverse transcription quantitative polymerase chain reaction
(RT-qPCR)
Total RNA was extracted from fresh or cultured primary B cells using the TRIzol method
(ThermoFisher Scientific, Rochester, NY). cDNA synthesis (iScript cDNA Synthesis Kit,
Bio-Rad, Mississauga, ON) was performed using equal starting RNA concentrations,
followed by RT-qPCR analysis, which was conducted using the SensiFAST SYBR NoROX Kit (Bioline, Singapore) on the QuantStudio 5 Real-Time PCR System
(ThermoFisher Scientific, Rochester, NY).
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Primer Name

Sequence (5’ – 3’)

Source

Spib KO fwd GGG CTC CTT GGC TTA TGC TCC
rev

CAG AAA GCG AAG GAG CAA AGC TG

Spib WT fwd GGG CTC CTT GGC TTA TGC TCC
rev

CGC GCT GTC AAA CTG GTA GGT

Spic KO fwd AAG CTT GGC TGG ACG TAA ACT CCT
rev

AGA ACC AAG ACT ACC AGC CCA GAT

Spic WT CGG CAG ACA CTT TGC TAT TTC
rev

CCT CAA CTG AAG CTC CTT TCT

Table 1. Primer sequences used for genotyping.
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(Kohyama et al., 2009)

Analyses were conducted in duplicates, with relative expression of target genes normalized
to that of Tata-binding protein (Tbp), and calculated as fold change using the comparative
threshold cycle (2-∆∆CT) method (Pfaffl, 2004). The selection of Tbp as a reference gene
was carried out, on the basis of its relative stability and high expression, by re-analysis of
previously published RNA-seq data (GEO accession code: GSE60927) (Shi et al., 2015),
in which the variance in log2FPKM values from sorted FO B cells, GC B cells, plasmablast
and PC subsets was compared. Amplification efficiencies were calculated for each primer
pair (Table 2) using calibration curves generated by triplicate doubling dilutions of total
splenocyte cDNA. Primer pairs with efficiencies ranging from 90-110% were used in the
study.

2.8 Production of retrovirus
MIG-3XFLAG-SpiB and MIG-3XFLAG-SpiC plasmids (herein referred to as MIG-SpiB
and MIG-SpiC, respectively) were generated as previously described (Xu et al., 2012).
Production of retroviral particles was achieved by the transfection of Platinum-E (Plat-E)
retroviral packaging cells with MIGR1, MIG-SpiB and MIG-SpiC plasmids using
polyethyleminine (PEIpro, PolyPlus, Illkirch, France) (Morita, Kojima, & Kitamura,
2000). Plat-E supernatant containing viral particles was harvested after 48 hours, and
transfection efficiency (GFP expression) was analyzed by flow cytometry.

2.9 Primary B cell transduction
Primary B cells were enriched from total splenocytes as above and stimulated in IL-4+IL5+CD40L (R&D Systems, Minneapolis, NE) overnight. Transduction of stimulated,
enriched B cells was performed by centrifugal infection at 2000 x g for 3 hours at 32 °C.
Following transduction, primary B cells were cultured for 3 days in complete RPMI
(Wisent, St-Bruno, Qc, Canada) containing IL-4+IL-5+CD40L (R&D Systems,
Minneapolis, NE), as described above.

2.10 Chromatin immunoprecipitation
Chromatin was prepared from pellets of 1 x 106 transduced, potently stimulated B cells as
described in (DeKoter et al., 2010). Protein-DNA cross-linking was performed using 1%
formaldehyde (MilliporeSigma, Darmstadt, Germany) and halted using glycine (1.25 M).
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Pellets were flash-frozen in liquid nitrogen prior to sonication. Thawed pellets were lysed
in lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris) supplemented with Halt Protease
Inhibitor (ThermoFisher Scientific, Rochester, NY), prior to sonication for 25 cycles using
the

Bioruptor

UCD-300

water

bath

sonicator

(Diagenode,

Sparta,

NJ).

Immunoprecipitation of FLAG-bound chromatin was performed using anti-FLAG
antibodies conjugated to magnetic beads, washed with 0.1% PBS-T (MilliporeSigma,
Darmstadt, Germany). Bead-bound chromatin was washed sequentially with Wash Buffer
I (0.1% SDS, 1% Triton, 2 mM EDTA, 20 mM Tris, 150 mM NaCl), Wash Buffer II (0.1%
SDS, 1% Triton, 2 mM EDTA, 20 mM Tris, 500 mM NaCl), Wash Buffer III (0.25 M
LiCl, 1% NP40, 1 mM EDTA, 20 mM Tris (pH = 8.0), 1% deoxycholate) and Tris-EDTA
buffer. DNA was eluted in elution buffer, and purified using QIAquick PCR Purification
Kit (Qiagen, Hilden, Germany). qPCR on purified DNA was performed as described
above, using primers targeting regions of interest (ROIs) and outlined in Table 2. Threshold
cycle values were used to calculate percent input. ROIs were identified by analysis of
published ChIP-seq data (GEO accession code: GSE58128) (Solomon et al., 2015). The
sequence of the Bach2 locus was submitted for multi-species conservation analysis
(PhastCons46wayPlacental) to ORCAtk (Version 1.0.0), with the following settings:
minimum conservation – 70%, minimum conserved region – 20. Motif discovery within
ROIs was performed using the MEME Suite, version 4.12.0 (Bailey & Elkan, 1994).

2.11 Statistical analyses
Statistical analyses were performed using Prism 6.0 (GrapPad, La Jolla, CA). Unless
otherwise indicated, the data presented herein was analyzed by one-way ANOVA, with
Tukey’s multiple comparisons test and p < 0.05 denoting significance.
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Primer Name

Sequence (5’ – 3’)

Bach2 CAT CTC TTC CTC TGC CCA GT
rev

AGA CAT GCC GTT CAA ACC AT

Bcl6 fwd CCT GTG AAA TCT GTG GCA CTC G
rev

CGC AGT TGG CTT TTG TGA CG

Source
(Kometani et al., 2013)
(Raczkowski et al.,
2013)

IRF4 fwd GAA AAT GGT TGC CAG GTG ACA G
rev

GCT TCA GCA GAC CTT ATG CTT G

Pax5 TCG GAC CAT CAG GAC AGG ACA
rev

GTT CCA CTA TCC TTT GGC GGA

Prdm1 fwd ACA TAG TGA ACG ACC ACC CCT G
rev

CTT ACC ACG CCA ATA ACC TCT TTG

Tpb fwd ACC GTG AAT CTT GGC TGT AAA C
rev

GCA GCA AAT CGC TTG GGA TTA

ChIP ROI 1 fwd GTG GTC GAT AGG GCA GCT ATT T
rev

CAA CTC ACT CTC CGT GTT TCA

ChIP ROI 3 fwd CGT AAG GCA GAG ATC CGA AGT
rev

CTT CCT TAC TGA GAA CTC CCT GG

ChIP NCR fwd ATA ACT ACT GTG GAT GCC CTC AC
rev

CAG GCT TTA GAC GAT GCC TGA TA

Table 2. Primer sequences used for qPCR analysis
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(Harada et al., 2012)

(Eissa et al., 2016)

3

Chapter 3: Results

3.1 Loss of Spi-C rescues Spib-/- defect in secondary T celldependent B cell responses
Mice harbouring a germline deletion of Spi-B on a BALB/c background have previously
been reported to elicit reduced titers of IgG1, IgG2a and IgG2b antibody isotypes in response
to secondary challenge with haptenated model antigen keyhole limpet hemocyanin (Su et
al., 1997). We sought to determine whether impairments in Spib-/- antibody-secreting cell
(ASCs) frequencies could be observed in a similar model of secondary T cell-dependent
immunization (Su et al., 1997). Spib-/-, Spib-/-Spic+/- and C57BL/6 (WT) mice were
immunized intraperitoneally with a priming dose of 4-hydroxy-3-nitrophenylacetyl (NP)
haptenated-ovalbumin (NP-OVA) precipitated in alum at day 0. An identical challenge was
administered at day 30 post-immunization, and splenic frequencies of ASCs were assessed
in both immunized and naïve mice by Enzyme-Linked ImmunoSpot (ELISpot) at day 37
post-immunization. For sex-matched Spib-/- and Spib-/-Spic+/- immunized litter mates, we
observed a general dominance of IgG1 responses over IgM, which was expected based on
the immunization strategy (Fig. 3-1A) (Xu et al., 2015). We additionally noted a moderate
decrease in the frequencies of Spib-/- IgG1, but not IgM, ASCs relative to WT mice (Fig. 31A). In agreement with earlier reports, loss of Spi-B corresponded to a significant reduction
in frequencies of NP-reactive, IgG1-forming ASCs in immunized Spib-/- mice, relative to
those observed in NP-sensitized WT controls (Fig. 3-1B, 3-1C). By contrast, IgG1 ASC
frequencies in Spib-/-Spic+/- mice were rescued to that of WT levels (Fig. 3-1B, 3-1C).
ELISpot analysis of IgM, IgG2b and IgG2c isotypes revealed normal frequencies of NPspecific ASCs in Spib-/- and Spib-/-Spic+/- mice, relative to their WT counterparts (Fig. 31D, 3-1E, 3-1F). No difference was detected with regards to the size (µm²) of IgG1 and
IgM spots across the genotypes of interest (data not shown). These results raise the
possibility that Spib-/- mice present with a defect in secondary responses. Moreover, rescue
of secondary Spib-/- IgG1 ASC frequencies by heterozygous loss of Spi-C suggests an
opposing role for Spi-C in regulating antibody-forming responses.
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Figure 3-1. Frequencies of secondary NP-specific IgG1-ASCs per 106 splenocytes in
immunized Spib-/- mice are decreased relative to WT mice, and rescued in Spib-/-Spic+/animals at 37 d.p.i. (A) ASC frequencies per 106 splenocytes obtained from one
representative male cohort. Black bars represent IgG1, while grey bars represent IgM, with
each bar representing a single mouse. ‘0’ denotes an absence of spots. Data points were
calculated from logarithmic functions, obtained by plotting mean values of spots from
triplicate wells against corresponding dilutions for each mouse. (B) IgG1-ASC frequencies
across immunized male and female cohorts. Horizontal bars represent mean ± SEM, n=10
for Spib-/- and Spib-/-Spic+/- mice, n=7 for WT mice. Data points were calculated as in (A).
(C) Representative ELISpot wells for IgG1 and IgM detection, from the single male cohort
shown in (A). Representative IgG2b and IgG2c wells. (D) IgM-ASC frequencies across
immunized male and female cohorts. Horizontal bars represent mean ± SEM, n=9 for Spib/-

and Spib-/- Spic+/- mice, n=7 for WT mice. Data points were calculated as in (A). (E, F)

IgG2b- and IgG2c-ASCs frequencies across immunized male and female cohorts. Horizontal
bars represent ± SEM, n=5 for Spib-/- and Spib-/- Spic+/- mice, n=3 for WT mice. Data points
were calculated as in (A). *p < 0.05, ns = non-significant, as per one-way ANOVA (twotailed).
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Based on previous reports that Spib-/- mice are capable of generating GCs which are poorly
sustained at 28 days, we sought preliminary evidence that Spi-C heterozygosity might
rescue the maintenance defect in Spib-/- GCs (Su et al., 1997). As per the ELISpot assay
outlined above, Spib-/-, Spib-/-Spic+/- and WT mice were immunized by i.p. injection with a
priming dose of NP-OVA, then re-challenged after 30 days. At day 37 post-immunization,
spleens were harvested and flow cytometric analysis was performed to characterize the
frequencies of splenic CD19+CD138-CD95hiCD38lo GC cells across our three genotypes
of interest (Fig. 3-2A). Samples were first gated on the live CD4-CD19+CD138- population
to exclude non-B lymphocytes and PCs from the analysis, and subsequently gated on GC
B cells, which express high levels of cell-surface CD95 (Fas), and low levels CD38 (Hao
et al., 2008; Oliver, Martin, & Kearney, 1997) (Fig. 3-2B). Despite n values too low to
permit statistical analysis, we observed a trend towards reduced frequencies of
CD95hiCD38lo cells in Spib-/- spleens, relative to that of the WT mouse—a reduction that
was seemingly rescued in the Spib-/-Spic+/- mice (Fig. 3-2C). These results suggest that
secondary GCs may be impaired in Spib-/- mice.

3.2 Spib-/- and Spib-/-Spic+/- spleens harbour normal primary
frequencies of IgG1-secreting cells relative to WT spleens
We have previously characterized a decrease in both the frequencies and absolute numbers
of splenic follicular (FO) B cells in Spib-/- mice, relative to both WT and Spib-/-Spic+/animals (Li et al., 2015). To determine whether the observed impairment in the dominant
IgG1-forming secondary responses of Spib-/- mice stem from diminished ‘steady-state’
frequencies of splenic FO B cells, we immunized Spib-/-, Spib-/-Spic+/- and WT mice using
NP-OVA in alum, and assessed ASC frequencies at day 7 post-immunization. At this
timepoint, we aimed to investigate a potential defect in ASC frequencies in the early stages
of the primary response. In accordance with previous reports (Su et al., 1996; Willis et al.,
2017), we observed normal primary frequencies of NP-reactive ASCs in responding Spib/-

and Spib-/-Spic+/- animals, across assayed IgG1, IgM, IgG2b and IgG2c isotypes (Fig 3A-

D). Spib-/- spleens consistently exhibited comparable frequencies of responding ASCs to
those of WT controls, despite a previously noted reduction of Spib-/- FO B cells in the
absence of immunization (Fig. 3-3A-D) (Li et al., 2015).
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Figure 3-2. Loss of Spi-C on a Spib-/- background may rescue defects in secondary
germinal centers formation or maintenance. (A) WT, Spib-/- and Spib-/- Spic+/- mice were
immunized with NP-OVA in alum at day 0, boosted on day 30 and sacrificed on day 37
for analysis. (B) Flow cytometry plots depicting frequencies of CD95hiCD38lo cells in Spib/-

and Spib-/- Spic+/- mice at the 37 days post-immunization timepoint. Samples were

initially gated on live cells using a live/dead stain, while lymphocyte and singlet
populations were identified based on light scatter properties. Subsequent gating on
CD19+CD138- and CD4- fractions was used to remove PCs and Tfh cells from the analysis.
(C) Quantitation of CD95hiCD38lo cells frequencies across WT, Spib-/- and Spib-/- Spic+/genotypes. Bars represent group means ± SEM, n=2 (Spib-/- and Spib-/-Spic+/-) and n=1
(WT).
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Figure 3-3. ASC frequencies from Spib-/- spleens are comparable to that of Spib-/Spic+/- and WT animals at 7 d.p.i. (A) Frequencies of IgG1-forming ASCs per 106
splenocytes across immunized male WT (n = 7), Spib-/- R (Responders) and Spib-/-Spic+/(n = 8), along with Spib-/- NR (Non-Responders) (n = 5) = mice. Horizontal bars represent
mean ± SEM. Data points were calculated from logarithmic functions, obtained by plotting
mean values of spots from triplicate wells against corresponding dilutions for each mouse.
(B) IgM-ASC frequencies across immunized and non-immunized males cohorts as in (A).
(C, D) IgG2b- and IgG2c-ASCs frequencies across immunized mice, n = 8. (E) ASC
frequencies per 106 splenocytes obtained from WT, responder and non-responder Spib-/and Spib-/-Spic+/- mice. White bars represent IgG1, while black bars represent IgM.
Horizontal bars represent ± SEM, data points were calculated as in (A). Statistics performed
using one-way ANOVA (two-tailed). (F) ELISpot wells for IgG1, IgM, IgG2b and IgG2c
detection from one representative cohort, showing immunized mice.
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Within immunized Spib-/- animals, we additionally noted a population of non-responder
(NR) mice, which failed to respond to the i.p. immunization protocol. NR mice comprised
35.7% of the immunized Spib-/- animals, and yielded no detectable class-switched ASCs,
along with IgM ASC frequencies comparable to that of those from non-immunized mice
(Fig. 3-3E). Taken together, these findings suggest that Spib-/- mice manifest a defect in
secondary responses to T cell-dependent immunization, which is rescued by heterozygous
loss of Spi-C.

3.3 Increased ASC differentiation in Spib-/- and Spib-/- Spic+/- B
cells ex vivo, relative to WT B cells
Multiple reports have described a redundant role for PU.1 and Spi-B in opposing plasma
cell differentiation (Carotta et al., 2014; Schmidlin et al., 2008; Willis et al., 2017; Xu et
al., 2015). Based on our observation that Spi-C heterozygosity rescues the impairment of
memory responses in Spib-/- mice, we hypothesized that Spi-C might act as a cell intrinsic
positive regulator of the plasma cell fate decision. To assess the respective capacities of
Spib-/- and Spib-/-Spic+/- B cells to terminally differentiate into CD138-expressing plasma
cells (PC), spleen-derived enriched B cells (~97%) (Fig. 3-4A) were stimulated under
modest or potent stimulation conditions, in the presence of CD40L and IL-4, or in media
containing a combination of CD40L, IL-4 and IL-5, respectively. Naïve enriched B cells
were stained with CellTrace Violet (CTV) and cultured for a period of 5 days. Extensive
proliferation of B cells was observed at day 4 of cultures (Fig. 3-5). The day 5 timepoint
was selected on the basis of maximized CD138 expression in samples stimulated for 5
days, relative to enriched B cell cultures of 3 and 4 days (Fig. 3-6A). Flow cytometric
analysis was performed to assess the proliferation and differentiation status of stimulated
WT, Spib-/- and Spib-/-Spic+/- B cells. Upon exposure to CD40L and IL-4, WT, Spib-/- and
Spib-/-Spic+/- enriched B cells differentiated into CD138+ cells to a similar extent over the
course of 5 days (data not shown). However, frequencies of CD138-expressing cells in
both Spib-/- and Spib-/-Spic+/- samples were significantly elevated upon addition of IL-5, as
compared to WT samples (Fig. 3-6B).
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Figure 3-4. B cell enrichment and PC depletion approaches. (A) Mature resting B cells
were enriched from whole WT spleens using biotinylated anti-CD43 antibodies, Miltenyi
streptavidin microbeads and magnetic columns. Pre-enrichment and post-enrichment
samples are shown, stained for cell-surface CD19 and B220. Samples were initially gated
on single cells using light scatter properties, as shown in the reduced ‘gating’ panels. (B)
Following CD43-based B cell enrichment, samples were stimulated for four days using
CD40L, IL-4 and IL-5, and subjected to CD138-based depletion using the Miltenyi system.
Samples were initially gated on single cells as above, and stained for CD138 and B220
expression.
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Figure 3-5. Phase-contrast micrographs of enriched B cells stimulated using IL-4, IL5 and CD40L for four days. Splenocytes from WT, Spib-/- and Spib-/- Spic+/- mice were
harvested on day 0 and enriched for mature resting B cells by means of CD43 negative
selection. Following CellTrace staining, enriched B cells were placed in culture under the
following condition: modest stimulation (IL-4+CD40L), potent stimulation (IL4+CD40L+IL-5) and no stimulation (RPMI only). Images were taken at 20X
magnification, using the Zeiss AxioObserver A1 and AxioCam ICM1. Scale bars represent
50 µm.
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Spib-/-Spic+/-

Figure 3-6. Spib-/- enriched B cells undergo accelerated terminal differentiation
relative to WT enriched B cells when stimulated with CD40L+IL-4+IL-5 (A) Overlaid
histograms of representative samples showing CD138 positivity in WT enriched B cells
cultured over the course of three (light grey), four (dark grey) or five (black) days in the
presence of CD40L, IL-4 and IL-5. Samples were initially gated on live, single cells using
light scatter properties. CD138 staining is shown on the x-axis. (B) Total frequencies of
plasma cells (CD138+) cells across WT, Spib-/- and Spib-/-Spic+/- samples following potent
stimulation at day 5 post-enrichment. Group means are shown ± SEM. **p < 0.01, as per
one-way repeated measures ANOVA (two-tailed). (C) Frequencies of plasma cells
(CD138+; upper horizontal gate) were quantified in WT, Spib-/- and Spib-/-Spic+/- enriched
B cells, following stimulation for 5 days under modest (CD40L+IL-4) or potent stimulation
(CD40L+IL-4+IL-5) conditions. Cells were pre-gated based on light scatter, and the ‘live’
population was identified by use of a live/dead stain. To control for differential staining
with CellTrace Violet across samples, cells were assigned to vertical gates representing
‘generations’. The rightmost gate denotes generation 1. Data shown are representative of
seven trials, with an n = 1 for each genotype per trial. (D) Frequencies of plasma cells
(CD138+B220lo) and undifferentiated (CD138-B220hi) cells were quantified for each
generation in WT, Spib-/- and Spib-/-Spic+/- enriched B cells, following stimulation for 5
days under modest (CD40L+IL-4) or potent stimulation (CD40L+IL-4+IL-5). Black bars
represent undifferentiated cell frequencies, while white bars represent differentiated cell
frequencies across seven independent trials. Group means are represented ± SEM, with
uppermost error bars removed for clarity. * p < 0.05, § p < 0.05, ** p < 0.01, as per twoway repeated measures ANOVA.
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To explore the kinetics of differentiation in successive rounds of CTV-labelled cellular
divisions, samples were gated on CD138-expressing cells within individual generations
(Fig. 3-6C). The use of an arbitrary generation-based analysis revealed a significant
increase in the proportion of Spib-/- CD138+ cells within the third round of cell division,
relative to that of modestly stimulated WT samples (Fig. 3-6D). Upon culture in IL-4,
CD40L and IL-5 supplemented media, we likewise noted a marked increase in the
proportion of Spib-/- CD138+ as early as the third generation, compared to WT enriched B
cell samples (Fig. 3-6D). The increase in the Spib-/- CD138+ compartment became more
pronounced in generations 4 and 5, and was eventually lost in subsequent generations (Fig.
3-6D). By contrast, Spib-/-Spic+/- subsets exhibited a seemingly intermediate phenotype
within both stimulation conditions (Fig. 3-6D). When stimulated using CD40L and IL-4,
Spib-/-Spic+/- showed no difference across generations when compared to either Spib-/- or
WT samples (Fig. 3-6D). Spib-/-Spic+/- samples showed an increase in the proportion of
CD138+ PCs in generation five alone, relative to the WT, when cultured in the presence of
IL-4, CD40L and IL-5 (Fig. 3-6D). These results highlight the accelerated differentiation
of Spib-/- enriched B cells into CD138-expressing PCs upon stimulation with CD40L, IL-4
and IL-5, which can partially be hampered by the concomitant loss of one functional SpiC allele.

3.4 Loss of Spi-B corresponds to decreased Bach2 expression in
potently stimulated enriched B cells
To investigate the mechanistic underpinnings of restrained PC differentiation in Spib-/Spic+/- enriched B cells, we sought to characterize the changes in gene expression incurred
by B cells upon stimulation across our genotypes of interest. As above, B cells were
enriched using CD43-based magnetic bead depletion and cultured for four days under
potent stimulation conditions (Fig. 3-4A). On the fourth day of stimulation, stimulated B
cells from WT, Spib-/- and Spib-/-Spic+/- mice were positively or negatively selected on the
basis of CD138 expression using magnetic beads (Fig. 3-4B). Total RNA was obtained
from CD138-enriched or –depleted fractions and used to interrogate the expression of
Blimp-1 (encoded by Prdm1), Pax5, Bach2, Bcl6, and IRF4 by reverse transcriptase
quantitative PCR (RT-qPCR).
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Gene

Mean Log2FKPM

Variance

FO B cells

GC B cells

Plasmablasts

Plasma cells

Actb

11.3643369

11.9691542

8.821832

8.68619092

2.470726185

B2m

11.3655073

9.01972367

13.1077274

12.8097644

2.911501739

Gapdh

2.68762562

2.91673168

2.83524299

4.28677542

0.310613562

Tbp

4.61012514

4.42165738

4.27496641

4.0909371

0.053256973

Ubc

5.43640604

4.85325435

5.47507066

5.663826

2.079389762

Table 3. Selected candidate reference genes
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Selection of an appropriate reference gene was carried out by re-analysis of RNA-seq data
sets originally published and made publicly available by Shi and colleagues (Shi et al.,
2015). These sets contained gene expression data from sorted follicular (n = 2) and GC B
cells (n = 2), along with sorted plasmablasts (PBs, n = 1) and PCs (n = 3), expressed as logtransformed fragments per kilobase of transcript per million mapped reads (log2FPKM).
The variance (σ2) of log2FPKM values for each gene were calculated across the sorted cell
subsets, using the equation σ2 = (∑ (X - µ)2/ n, wherein X denotes individual data point, µ
represents the mean log2FPKM for each gene and n signifies the total number of subsets
and their replicates (n = 8). We narrowed our analysis to genes commonly used or
previously identified in the literature as reference in leukocyte gene expression analyses—
such as the genes encoding glyceraldehyde-3-phosphate dehydrogenase (Gapdh), β-actin
(Actb), β-2 microglobulin (B2m), ubiquitin C (Ubc), and TATA-binding protein (Tbp)
(Mosley & Hogenesch, 2017; Zhang, Ding, & Sandford, 2005). Within this narrow gene
list, Ubc, Actb and B2m exhibited the largest variance in expression, with σ2 values of 2.08,
2.47 and 2.911, respectively (Table 3). While Gapdh expression fluctuated substantially
less than that of the common housekeeping gene Actb, Tbp expression varied least during
the fate differentiation event from mature B cell to plasma cell, with an σ2 of 0.05 (Table
3). These results suggest that Tbp might be a suitable reference gene following stimulation
of ex vivo primary B cells.
Following inter-sample normalization to Tbp transcripts, we found mRNA transcript levels
of Prdm1 to be significantly elevated across WT, Spib-/- and Spib-/-Spic+/- CD138-enriched
samples, relative to that of the WT CD138-depleted fraction, as would be expected based
on the differentiation of B cells into plasma cells (Fig. 3-7A). Levels of Pax5 were
significantly decreased in both Spib-/- and Spib-/-Spic+/- CD138+ samples, relative that of
WT CD138- samples (Fig. 3-7B). The marked decrease in Pax5 expression in Spib-/- and
Spib-/-Spic+/- PCs suggests a more pronounced, or rapid loss of B cell identity than that
which occurs within the WT CD138+ subsets (Fig. 3-7B). With regards to Bach2
expression, levels of Bach2 transcript were significantly downregulated in Spib-/- CD138+
samples, but not in corresponding WT or Spib-/-Spic+/- CD138-expressing subsets (Fig. 37C).
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Figure 3-7. Loss of Spi-B or Spi-C on Spib-/- background alters the expression of genes
which direct the maintenance of B cell, GC B cell and PC identities. (A-E) RT-qPCR
analysis was performed for the indicated genes using whole RNA prepared from CD138enriched and –depleted samples (n = 3), following four days of culture in complete RPMI
supplemented with CD40L+IL-4+IL-5. Relative gene expression was analyzed using the
2-ΔΔCT method, and normalized to Tbp expression. Fold change in expression relative to
WT CD138- cells is shown as mean ± SEM. * p < 0.05, ** p < 0.01, as per Kruskal-Wallis
test, with Dunn’s multiple comparisons test.
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Differentiation of enriched B cells into CD138+ cells was likewise correlated with a
significant downregulation of Bcl6 mRNA in both Spib-/- and Spib-/-Spic+/- subsets, but not
in WT CD138+ samples (Fig. 3-7D). IRF4 mRNA transcript levels followed pattern of
expression reminiscent of Prdm1, which was expected based on the documented regulation
of Prdm1 by IRF4 (Sciammas et al., 2006). IRF4 mRNA levels were significantly
increased in WT, Spib-/- and Spib-/-Spic+/- CD138+ samples (Fig. 3-7E). The above results
indicate that loss of Spi-B or Spi-C on a Spib-deficient background alters the transcriptional
landscape which directs the maintenance of B cell, GC B cell and PC identities, promoting
gene expression patterns which support plasma cell differentiation.

3.5 Analysis of PU.1, Spi-B and Spi-C binding within the Bach2
locus
The observed downregulation of Bach2 in CD138-expressing Spib-/-, but not in Spib-/Spic+/- or WT subsets, rendered the gene an attractive candidate for opposing transcriptional
regulation by Spi-B and Spi-C. We sought further evidence for the potential regulation of
Bach2 by Spi-B and or Spi-C. We observed a reduction in the relative levels of Bach2
transcripts in B cells enriched from the spleens of Spib-/-Spic+/- animals, relative to that
found in WT samples (Fig. 3-8A). Re-analysis of RNA-seq data sets from sorted FO B
cells, GC B cells, PBs and PCs (Shi et al., 2015) additionally revealed that Spi-B and Bach2
exhibit similar expression patterns during B cell terminal differentiation (Fig. 3-8B,C).
While Spib and Bach2 expression remains high in the GC compartment, their expression
is substantially downregulated following commitment to the PC fate (Fig. 3-8B,C). By
contrast, Spi-C expression is seemingly repressed in GC B cells, and experiences
progressive upregulation through the PB and terminal PC stages (Fig. 3-8D). The inversely
correlated expression patterns of Spi-B and Spi-C in these cellular subsets lends support to
their displaying opposing roles in B cell terminal differentiation.
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Figure 3-8. Spi-B and Bach2 expression patterns during B cell terminal
differentiation are highly concordant. (A) RT-qPCR analysis of Bach2 expression in
splenic enriched B cells from the indicated genotypes (n = 4). Relative gene expression
was analyzed using the 2-ΔΔCT method, and normalized to Tbp expression. Fold change in
expression relative to WT enriched B cells is shown as mean ± SEM. * p < 0.05 as per
Friedman test, with Dunn’s multiple comparison test. (B-D) Re-analysis of RNA-seq data
sets from (Shi et al., 2015), depicting the normalized expression of Spi-B (B), Bach2 (C)
and Spi-C (D) in sorted FO B cells (n = 2), GC B cells (n = 2), plasmablasts (PBs, n = 1)
and splenic PCs (n = 3). Bars represent mean Log2FKPM values ± SEM.
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To determine whether evidence of Spi-B or PU.1 binding could be observed within the
Bach2 gene locus, previously published anti-FLAG chromatin immunoprecipitation and
next-generation sequencing (ChIP-seq) of WEHI-279 lymphoma cells, transduced with
3XFLAG-tagged PU.1 and Spi-B, was re-analyzed for the purpose of our study (Solomon
et al., 2015). Though a number of PU.1 and Spi-B interaction sites were identified
throughout intronic regions of the Bach2 locus, few sites of PU.1 and Spi-B enrichment
was found to be located within 15 kb of the transcription start site (Fig. 3-9B).
Four peaks were arbitrarily defined as regions-of-interest (ROI) for potential regulation of
Bach2 expression based on enrichment of PU.1 and Spi-B binding (Fig. 3-9B). We
additionally examined Spi-C enrichment within the defined ROIs, using ChIP-seq
performed in MIG-3XFLAG-SpiC-transduced 38B9 pro-B cells. We observed a moderate
peak of Spi-C binding within ROI 1, but not in ROIs 2-4 (Fig. 3-9B). Multi-species
conservation analysis (PhastCons46wayPlacental) of ROIs was performed using the
publically available ORCA toolkit, and revealed a high degree of conservation in ROIs 1
and 3, found in Bach2 introns 1 and 2, respectively (Fig. 3-9C). The MEME Suite, which
was used to confirm the presence of GGAA motifs within ROIs, identified GAGG/AAA
as the top enriched motif (data not shown).
To examine whether Spi-B and Spi-C bound ROIs in stimulated B cells, enriched WT B
cells were stimulated overnight in IL-4, IL-5 and CD40L, then transduced using retrovirus
carrying MIG-3XFLAG-SpiB, MIG-3XFLAG-SpiC or with an empty MIGR1 vectors
(Fig. 3-9D). Chromatin from transduced and stimulated B cells was immunoprecipitated
using anti-FLAG antibodies, and used as input for qPCR targeting highly conserved ROIs
1 and 3, and on a negative control region (NCR) selected from intron 2 of Bach2 (Fig. 39B). Mean transduction efficiency, as determined by percentage of GFP+ cells, ranged from
55.80% (SD: 3.205) in MIGR1-transduced cells, to 16.30% (SD: 3.724) and 14.87% (SD:
4.829) in MIG-3XFLAG-SpiB and SpiC-infected cells, respectively (Fig. 3-9E). Percent
input analysis revealed significant enrichment of Spi-C at ROI 1 and 3, relative to the NCR
and compared to that of MIGR1-transduced cells (Fig. 3-9F-H). Spi-C binding at ROI 3
suggests a specific interaction of Spi-C and the Bach2 gene locus in activated B cells, as
no such enrichment was predicted from the ChIP-seq data in 38B9 cells. Direct Spi-B
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binding was likewise observed at ROI 3, compared to basal MIGR1 and NCR enrichment
(Fig. 3-9F,H). Together, our data indicates that Spi-B and Spi-C are capable of binding
intronic regions of Bach2 directly, and may be involved in the regulation of Bach2
expression in stimulated B cells.
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Figure 3-9. Potential regulation of Bach2 expression by SPI subfamily transcription
factors PU.1, Spi-B and Spi-C. (A) RT-qPCR analysis of Bach2 expression in splenic
enriched B cells from the indicated genotypes (n = 4). Relative gene expression
was normalized to Tbp expression. Fold change in expression relative to WT enriched B
cells is shown as mean ± SEM. * p < 0.05 as per Friedman test, with Dunn’s multiple
comparison test. (B) UCSC genome browser tracks of ChIP-seq analysis of 3XFLAGtagged PU.1 and Spi-B in WEHI-279 lymphoma cells, along with 3XFLAG-tagged Spi-C
in 38B9 pre-B cell line. Two common Bach2 isoforms are shown below, with black boxes
denoting exons and lines representing introns. Red boxes indicate regions-of-interest
(ROIs), while the blue box denotes the negative control region (NCR). (C) Multiple
placental species conservation analysis (in red) the visualized as superimposed USCS
tracks of ROIs (peaks 1-4, in black) within the Bach2 locus for PU.1 and Spi-B. (D)
Schematic depicting the workflow for primary B cell transduction, followed by chromatin
immunoprecipitation (ChIP). (E) Frequency of GFP+ cells, 48 hours following transduction
of WT enriched B cells with the indicated retroviral vectors. Bars represent the mean
transduction efficiency (n = 3) ± SEM. (F-H) Enrichment of FLAG-tagged Spi-B and SpiC in stimulated WT B cells at the NCR (F), ROI 1 (G) and ROI 3 (H). Results are shown
as percentage of input DNA, with bars representing mean % input ± SEM from three
independent experiments. * p < 0.05, ** p < 0.01 as per one-way ANOVA, performed with
Tukey’s multiple comparisons test.
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Chapter 4: Discussion
4.1

General Discussion

The mouse B cell lineage lends itself as a relevant model to the study of cell fate
determination throughout immune responses. The distinct B lymphocyte populations
which arise from mature precursors, following a T cell-dependent immunogenic challenge,
are relatively well known, having been the focus of extensive characterization efforts (De
Silva & Klein, 2015a; Nutt et al., 2015). Analysis of these various subsets—utilizing
characteristics such as cell-surface markers, Ig isotype, mutational burden, etc.—allows for
gain of insight into the robustness and quality of humoral immune responses. While the
characteristics of antibody-forming effectors have largely been established, the manner in
which activated B cells undergo fate decisions between the plasmacytic and memory fates
remains elusive.
The purpose of the present study was to explore the role of Spi-C in antibody-forming
responses and activated B cell fate decisions. Herein, we showed that Spi-C heterozygosity
on a Spib-/- background rescues the reductions in ASC frequencies observed in Spib-/- mice,
following prime-boost immunization with model antigen NP-OVA. Preliminary evidence
suggests that Spib-/- secondary GC formation may be impaired, 7 days following a
secondary immunogenic challenge. Through ex vivo T cell-dependent-type stimulation of
spleen-derived enriched B cells, we revealed an increased tendency for both Spib-/- and
Spib-/-Spic+/- B cells to differentiate into CD138-expressing ASCs, relative to WT cells.
Whereas stimulated Spib-/- B cells underwent accelerated differentiation at earlier cell
divisions, Spib-/-Spic+/- B cells exhibited an intermediate phenotype, compared to the WT.
Gene expression analysis performed using Spib-/- and Spib-/-Spic+/- CD138+ B cells
indicates that loss of Spi-B and Spi-C alters the expression of genes which influence
activated B cell fate decisions. In the case of Spi-B deletion, these changes are conducive
to differentiation into the PC fate. Bach2 was identified as a candidate gene for putative
regulation by Spi-B and Spi-C. By ChIP-PCR, we showed that Spi-B and Spi-C bind
directly to intronic regions of the Bach2 locus. Together, our results suggest that Spi-C is
involved in shaping antibody-forming responses, by influencing the differentiation of
activated B cells in opposition to Spi-B.
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PU.1 and Spi-B exhibit a large degree of functional redundancy in the B cell lineage (RayGallet, Mao, Tavitian, & Moreau-Gachelin, 1995; Solomon et al., 2015). Germline ablation
of PU.1 in mice has long been known to generate nonviable offspring, which lack both
myeloid and lymphoid lineages (McKercher et al., 1996; Scott et al., 1994). By contrast,
Spib-/- mice are capable of producing mature B cells, though these cells exhibit marked
proliferation defects in response to BCR stimulation (Garrett-Sinha et al., 1999; Li et al.,
2015; Su et al., 1997). We have previously shown that spleens from Spib-/- animals contain
reduced numbers of mature follicular (FO) B cells and transitional type 2 (T2) B cells (Li
et al., 2015). Spi-B deficiency has previously been documented to bear functional
significance during B cell antibody-forming responses in vivo (Su et al., 1997). While titers
of class-switched antibodies appear normal during T cell-dependent primary responses,
Spib-/- mice display an impaired ability to generate secondary titers of IgG1, IgG2a and IgG2b
isotypes (Su et al., 1997). Our work corroborates a deficiency of Spib-/- mice during
secondary challenges to the T cell-dependent antigen NP, despite a lack of observable
defects during primary responses, in relation to that of WT mice. This defect was
specifically observed in frequencies of IgG1-producing ASCs, which secrete the dominant
class-switched isotype generated in responses to NP-OVA immunization (Xu et al., 2015).
The use of ELISpot assays enabled the analysis of responding cell frequencies, as opposed
to circulating antibody titers. While we cannot rule out a putative reduction in the quantity
of antibodies produced on a per cell basis, it is likely that these secondary antibody-forming
defects arise primarily due to a decrease in the splenic frequencies of ASCs in Spib-/animals. The capacity for Spi-C heterozygosity to rescue this apparent memory defect
highlights a novel role for this factor in regulating Ab-forming responses.
The mounting of humoral immune responses is a highly complex and dynamic process,
involving the coordinated activation of numerous cell types—including DCs and antigenspecific T cells and B cells (Parham, 2015). The observed impairments during Spib-/- recall
responses could thus be owed to a number of discrete, B cell-intrinsic or extrinsic defects.
One potential explanation is that Spib-/- mice present with defects in the MBC compartment,
which may account for impaired antibody-forming responses upon secondary antigenic
challenge. More specifically, Spib-/- mice could exhibit reduced frequencies of MBCs, or
functionally defective MBCs of similar abundance than those found in WT mice.
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Reductions in MBC frequencies could feasibly contribute to impaired recall responses in
Spib-/- mice by hampering the formation of secondary GCs (Wang et al., 2017). Our
preliminary flow cytometric analyses of GCs at 37 d.p.i. seem to support the notion that
Spib-/- mice exhibit defective secondary GCs. Interestingly, GC B cell frequencies may be
rescued in Spib-/-Spic+/- spleens. We considered the possibility that impaired recall
responses in Spib-/- mice might be the result of short-lived, or otherwise faulty memory TB interactions, as genetic ablation of Spi-B in T cells might generate T cell-intrinsic defects
(Su et al., 1996). While we are currently unable to rule out memory T cell defects, we
showed that enriched Spib-/- B cells, stimulated ex vivo in the presence of excess T cellderived signals, such as CD40L, IL-4 and IL-5, exhibit an intrinsic propensity towards ASC
differentiation. These results, considered alongside in vivo evidence of a memory defect,
have led us to hypothesize that loss of Spi-B promotes ASC differentiation at the expense
of MBC differentiation. Correspondingly, loss of Spi-C might de-repress MBC
differentiation, and alleviate the impairment in recall responses observed in Spib-/- mice.
Under the most prevalent paradigm, activated B cells are thought to undergo a bifurcation
in developmental outcomes, wherein a subset of GC B cells differentiates into ASCs, and
another, into MBCs (Xu et al., 2015). Our present work, along with that of others, indicates
that loss of Spi-B predisposes B cells to differentiate into PCs (Schmidlin et al., 2008;
Willis et al., 2017). Despite similar frequencies of CD138+ ASCs having been generated
by both Spib-/- and Spib-/-Spic+/- cultures following stimulation, we observed a modest lag
in the frequencies of Spib-/-Spic+/- CD138+ ASCs in early rounds of CTV-labelled cell
divisions. This delay suggests that loss of Spi-C decelerates PC differentiation in Spi-Bdeficient B cells, and that Spi-C may thus act as a pro-plasmacyte fate transcription factor
in activated B cells. Gene expression analysis of stimulated WT, Spib-/- and Spib-/-Spic+/- B
cells further supports an intrinsic bias of Spib-/- towards ASC differentiation, which is at
least partially countered by concurrent loss of one allele of Spi-C.
Putative functional impairments in the Spib-/- MBC compartment could stem from intrinsic
or extrinsic MBC defects. Intrinsic defects, such as an altered treshold of re-activation, or
failure to obtain sufficient help from primed T cells might underlie the observed defects in
Spib-/- recall responses (Ochsenbein et al., 2000). By contrast, MBC extrinsic activation
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requirements have been suggested to include the proper homing of MBCs to specific
lymphoid compartments (Elgueta et al., 2015; Hebeis et al., 2004). To our knowledge,
studies investigating the requirements for MBC reactivation, in the context of antigen reexposure, are scarce. One such study, however, outlines the critical role of BCR signalling,
via the Ig tail tyrosine motif, in MBC maintenance and re-activation (Lutz et al., 2015).
BCR signalling was shown to enhance the ability of IgG-switched MBCs to reactivate and
differentiate into ASCs, in the absence of T cell help (Lutz et al., 2015). The importance of
both tonic and episodic BCR signal transduction in MBC function is highly relevant to the
antibody-forming defects demonstrated in Spib-/- mice during secondary antigenic
challenge. Spi-B is known to coordinate the induction of genes involved in BCR signaling,
such as Blnk, Syk and Grap2 (Bednarski et al., 2016; Garrett-Sinha et al., 2005; Xu et al.,
2012). Correspondingly, our group has previously shown that Spi-B-deficient B cells
demonstrate proliferation defect following stimulation with anti-IgM antibodies, and that
heterozygous loss of Spi-C rescues this phenotype (Li et al., 2015). We speculate that BCR
signaling defects in Spib-/- MBCs hamper the ability of these cells to reactivate, which
manifests in impaired recall responses to T cell-dependent antigens. The observed rescue
of secondary IgG1 responses in Spib-/-Spic+/- mice might correspondingly be expected to
originate from de-repression of BCR signaling target genes regulated by Spi-C—namely
of Btk, Blnk and Syk (Bednarski et al., 2016; Zhu et al., 2008).
The work presented herein is, to the best of our knowledge, the first report of a potential
defect in the early primary responses of Spib-/- mice to haptenated antigens. The ‘nonresponder’ phenotype, which presented as a complete lack of class-switched ASCs in a
subset of NP-OVA-immunized Spib-/- mice, has not been observed as part of other studies
investigating T cell-dependent responses in these mice (Su et al., 1997; Willis et al., 2017).
DNP-specific IgM and IgG1 antibody titres remained unchanged in Spib-/- and Spib+/- mice
relative toWT controls, when assayed at days 5 and 8 post-immunization with DNP-KLH
(Su et al., 1997). In concordance with both our work and that of Su et al., Willis and
colleagues reported normal frequencies of NP-specific, IgG1-switched ASCs by ELISpot
analysis conducted 14 days post-immunization (Su et al., 1997; Willis et al., 2017). Both
of the previous works outlined make no mention of a non-responder phenotype. Given the
apparent defect that we and others have identified in Spib-/- secondary responses, the
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possibility of faulty primary immunizations requires careful consideration. In our view,
this potential explanation is limited by the lack of non-responders in control mice, and by
the immune profile of Spib-/- mice following a secondary immunogenic challenge. Despite
their reduced frequencies of IgG1-producing ASCs at day 37 post-immunization, Spib-/mice still exhibit IgG1-dominated responses–patterns of class-switching which are
inconsistent that of primary responses. To confirm the existence of the non-responder
phenotype, Spib-/- mice could be immunized with a panel of additional T cell-dependent
immunogens, such as haptenated KLH, chicken γ globulin (CGG) or sheep red blood cells
(SRBC), and their spleens analyzed by flow cytometry using 4-hydroxy-3-iodo-5nitrophenylacetate (NIP)-conjugated reagents, in order to identify hapten-specific
responding cells (Tomayko, Steinel, Anderson, & Shlomchik, 2010).
Impairments in GC reactions stand as another potential explanation for the observed
reductions responding B cell frequencies of Spib-/- mice. The internal complexity of GCs
likely renders these structures sensitive to subtle alterations in gene expression. We
speculate that loss of Spi-B could contribute to possible impairments in initial
establishment, maintenance, GC B cell selection and recirculation—processes which may
ultimately affect GC output (De Silva & Klein, 2015b). Evidence of GCs defects have
previously been reported in Spib-/- mice (Su et al., 1997; Willis et al., 2017). Early reports
showed that primary Spib-/- GCs are small and poorly sustained at day 28 postimmunization, relative to WT mice (Su et al., 1997). The premature collapse of Spib-/- was
largely attributed to increased apoptosis of GC B cells in the absence of Spi-B (Su et al.,
1997). Sfp1+/-Spib-/- mice, which lack Spi-B and harbour one functional PU.1 allele, fail to
generate splenic GCs following immunization (Garrett-Sinha et al., 1999). These reports
support the notion that PU.1 and Spi-B jointly contribute to both GC formation and
maintenance. By contrast, the role of Spi-C with regards to GC establishment and
maintenance is currently unknown. The potential rescue of GC B cell frequencies in
secondary Spib-/-Spic+/- GCs may contribute to restored frequencies IgG1-ASC frequencies
observed at 37 d.pi. Our results prompt us to speculate that Spi-C may be involved in
negatively regulating GC reactions, by exerting transcriptional repression over Bach2.
Further, and despite the involvement of BCR signaling in GC B cell selection remaining
controversial, we speculate that impaired BCR signaling in Spib-/- GC B cells might be
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linked to increased intra-GC apoptosis or aberrant affinity-based B cell selection into the
PC or MBC compartments (Su et al., 1997). Sequencing and mutation analysis of variable
heavy Ig regions from sorted GC B may provide insight into the affinity profile of Spi-B
and Spi-C deficient mice (Preite et al., 2015). Further microscopy experiments with EµSpi-C+ mice will be required to visualize the importance of Spi-C regulation in both
primary and secondary GCs.
The ChIP-PCR analysis conducted as part of our study has identified putative regulatory
regions within the Bach2 locus, which were bound by Spi-B and Spi-C. Our report is not
without precedent, however, as transcriptional cross-talk between Ets family members and
the BTB Domain and CNC Homologue (Bach) factors has previously been documented.
Within the monocyte lineage, Bach1 directs the transcriptional repression of Spi-C in the
absence of heme (Haldar et al., 2014; Kohyama et al., 2009). Heme-induced degradation
of Bach1 results in the upregulation of Spi-C, which itself mediates the differentiation of
monocytes into heme-scavenging red pulp macrophages (Haldar et al., 2014; Kohyama et
al., 2009). The closely-related, B cell-restricted factor Bach2 presents as an interesting
potential regulatory element in the context of activated B cell fate decisions. Induction of
Bach2 in GC B cells is known to inhibit PC differentiation, owing in part to its ability to
directly repress Blimp-1 (Huang, Geng, Boss, Wang, & Melnick, 2014; Ochiai et al., 2008).
High levels of Bach2 promote commitment of low-affinity activated B cells to the memory
B cell fate in a Blimp-1-independent manner, while repression of Bach2 in IgG1 MBCs
favours plasma cell generation (Kometani et al., 2013; Shinnakasu et al., 2016). Bach2-/mice exhibit, upon TD immunization, impairments in GC formation and CSR (Muto et al.,
2004). In this study, we have shown that levels of Bach2 mRNA are decreased in Spib-/Spic+/- enriched splenic B cells, relative to that of WT mice. Upon stimulation in Th2-like
conditions, differentiated Spib-/- cells, but not CD138+ Spib-/-Spic+/- or WT cells, exhibit
reduced levels of Bach2 transcripts compared to non-differentiated WT cells. More
specifically, Spi-B and Spi-C enrichment was demonstrated at two intronic sites of Bach2,
suggesting their potential role as transcriptional regulators of Bach2 expression in activated
B cells. While some evidence indicates that human Spi-B directly represses Prdm1
(Schmidlin et al., 2008), our data suggests that Spi-B may indirectly exert regulation over
Blimp-1 expression via induction of Bach2. Establishing the role of Spi-C with regards to
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Bach2 expression requires further analysis, due to Spi-C’s documented ability to function
as either an activator or repressor of transcription in B cells (Carlsson et al., 2003; DeKoter
et al., 2010; Li et al., 2015; Schweitzer et al., 2006; Zhu et al., 2008).
The long-term aim of our work is to understand the regulatory contributions of Ets-family
transcription factors PU.1, Spi-B and Spi-C in guiding B cell development and enabling
mature B cell functioning. The governing hypothesis driving our investigation was that
Spi-C opposes the regulatory function of Spi-B in B cell antibody-forming responses. The
results presented herein were shown to support our hypothesis, as loss of Spi-C restored
the reduced frequencies of antibody-forming cells generated by Spib-/- mice. Taken
together, our study highlights a previously uncharacterized role for the Ets-family
transcription factor Spi-C in regulating ASC differentiation, along with antibody-forming
responses to both primary and secondary antigenic challenge. Further analysis is required
to identify the specific function of Spi-C on the transcription of its target genes in the
context of activated B cell fate decisions, as well as its impact on GC reactions.
Understanding the molecular circuitry which governs B cell fate decisions during immune
responses may ultimately bear important implications for the design of vaccination
strategies, which aim to provide high levels of protective antibody titers over long periods
of time.

4.2

Future Directions

The work conducted as part of this thesis has identified a novel role for Spi-C in regulating
antibody-forming responses during T cell-dependent responses, along with a potential
mechanism for the respective positive and negative regulation exerted by Spi-C and Spi-B
on terminal B cell differentiation. Despite direct binding of Spi-B and Spi-C having been
shown to occur at intronic regions of Bach2 at the activated B cell stage, the specific
regulatory function of these factors at identified target sites remains to be established.
Previous work from our laboratory has led to the hypothesis that Spi-B and Spi-C act as
mutually antagonistic factors in the regulation of Nfkb1 in B cells primarily through their
competition of occupancy at shared regulatory binding sites (Li et al., 2015). This
hypothesis remains pertinent in view of the putative regulation of Bach2 by the
transcription factors Spi-B and Spi-C.
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The impairment in recall responses exhibited by Spib-/- mice, along with their apparent
rescue in Spib-/-Spic+/- littermates prompts an investigation into GC and memory formation.
To first characterize the GC phenotype of Spib-/-Spic+/- mice, we propose to perform
immunofluorescence microscopy experiments to examine splenic GCs at 10, 28 and 37
d.p.i. While the first two timepoints would provide information regarding primary GCs and
their maintenance, the 37 d.p.i timepoint would enable us to visualize secondary GCs. A
tricolor panel for IgD, PNA or GL-7 and anti-CD35 would be utilized to quantitatively
compare GC size, and % of GC-positive follicles within splenic sections of Spib-/-Spic+/-,
Spib-/- and WT mice. IgD staining is generally used to identify B cell follicles, which are
primarily colonized by naïve IgD+ B cells. PNA and GL-7 have classically been used to
stain GC B cells of the DZ, while CD35 identifies follicular dendritic cells in the LZ (Imai
& Yamakawa, 1996).
To investigate potential defects in the Spib-/- memory compartment, we propose to conduct
an in vivo functional assay. We will first immunize Spib-/-, Spib-/-Spic+/- and WT with
haptenated ovalbumin at two separate time points, one week apart, to allow for the robust
generation of memory. Following the second immunogenic challenge, the mice will be
rested for at least five weeks. At this 7 week time point, the mice will be sacrificed, and
their spleens harvested. B cells will be enriched from splenocytes using the Miltenyi
system, and transferred intravenously into immunodeficient Rag1 knockout recipient mice,
as described in (Lutz et al., 2015). Following a third challenge with NP-KLH, flow
cytometry will be performed on the spleens of recipient mice to detect frequencies of
CD138+ ASCs—which would have arisen primarily through the reactivation of previously
generated MBCs. We hypothesize that Rag1 knockout mice which received cells obtained
from Spib-/- mice will exhibit impaired antibody-forming responses, while recipients
having received Spib-/-Spic+/- and WT enriched B cells will fare comparably well. The
experimental protocol outlined above could be modified to examine NP-specific antibody
titres in recipient mice, or be used to sort MBCs from our genotypes of interest to perform
ex vivo assays such as ELISpots. The goal of these experiments would be to establish a role
for Spi-B and Spi-C in memory formation.
Transcriptional regulation of terminal B cell differentiation and antibody-forming
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responses by SPI subfamily members in relation to the heme-binding Bach factors merits
further investigation. While our work puts forth the idea that Spi-B and Spi-C might oppose
each other for transcriptional control of the Bach2 locus, countervailing regulation by
Bach2 over the Ets factors must also be considered. It is conceivable that Bach2 could be
involved in the transcriptional regulation of Spi-C, as the closely-related factor Bach1 has
previously been shown to repress Spi-C expression in monocytes (Haldar et al., 2014).
Interestingly, the addition of heme to LPS-stimulated B cell cultures has previously been
shown to promote PC differentiation in a Bach2-dependent fashion (Watanabe-Matsui et
al., 2011). These results raise the possibility that an abundance of heme could mediate
increased PC differentiation by inducing Spi-C expression. We hypothesize that Bach2 and
Spi-C comprise a feed-forward, negative regulatory loop in activated B cells, which is
initiated at the GC stage (Fig. 4-1). Bach2 expression is elevated in GC B cells, possibly
serving to maintain repression at the Spi-C locus. During terminal differentiation, Bach2
is downregulated, potentially allowing for the de-repression of the Prdm1 and Spic loci.
Elevated expression of Spi-C in PBs would eventually support repression at the Bach2
locus throughout their entering the PC stage. Overall, the putative net impact of Spi-C
upregulation would be to support PC differentiation via repression of Bach2.
To explore the possibility of heme-mediated transcriptional regulation of Spi-C during
antibody-forming responses, several experiments can be proposed. The observation that
heme induces PC differentiation in LPS-stimulated B cells would first need to be validated
using our own ex vivo T cell-dependent-type stimulation assay—using flow cytometry to
determine frequencies of CD138-expressing cells.
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Figure 4-1. Schematic for the potential feed-forward negative regulatory loop of SpiC and Bach2 expression. In GC B cells, expression of Bach2 is high, which maintains
repression at the Spi-C locus. During a plasmacytic differentiation event, Bach2 is
downregulated, allowing for the de-repression of Blimp-1 and Spi-C. Elevated expression
of Spi-C in plasma cells eventually helps to maintain repression at the Bach2 locus. High
concentrations of heme, or heme metabolites, have been demonstrated to induce Spi-C
expression in monocytes, which suggests a potential role for heme-mediated regulation of
plasma cell differentiation.
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If our hypothesis is correct, exposure to heme would result in a more dramatic increase in
Spi-C expression during PC differentiation. Evidence of Bach2 enrichment near the Spic
locus could be obtained by re-analysis of available Bach2 ChIP, and might instruct future
chromatin conformation capture (3C) assays in identifying potential distal enhancers of
Spic (Hagège et al., 2007). Moreover, it is known that certain human hematopoietic
disorders, such as β-thalassemia major, involve the release of abundant quantities of heme
into circulation upon widespread hemolysis (Garcia dos Santos et al., 2015). Human blood
or spleen samples, obtained by splenectomies performed to mitigate the condition, may be
useful in determining whether abundant quantities of heme can alter the immune profile of
individuals, by promoting PC differentiation. Ultimately, these studies would seek to
generate greater insight into the roles of Ets factors Spi-B and Spi-C during B cell
responses, and identify potential translational research opportunities to study these factors
in the context of human disease.
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